<?xml version="1.0" encoding="UTF-8"?>
<GoldLabel drug="CYTOXAN">
  <Text>
    <Section id="S1" name="adverse reactions">  6 ADVERSE REACTIONS

  The following adverse reactions are discussed in more detail in other sections of the labeling.

 *    Hypersensitivity [see  Contraindications (4)  ] 
 *    Myelosuppression, Immunosuppression, Bone Marrow Failure, and Infections [see  Warnings and Precautions (5.1)  ] 
 *    Urinary Tract and Renal Toxicity [see  Warnings and Precautions (5.2)  ] 
 *    Cardiotoxicity [see  Warnings and Precautions (5.3)  ] 
 *    Pulmonary Toxicity [see  Warnings and Precautions (5.4)  ] 
 *    Secondary Malignancies [see  Warnings and Precautions (5.5)  ] 
 *    Veno-occlusive Liver Disease [see  Warnings and Precautions (5.6)  ] 
 *    Embryo-Fetal Toxicity [see  Warnings and Precautions (5.7)  ] 
 *    Reproductive System Toxicity [see  Warnings and Precautions (5.8)  and  Use in Specific Populations (8.4  and  8.6)  ] 
 *    Impaired Wound Healing [see  Warnings and Precautions (5.9)  ] 
 *    Hyponatremia [see  Warnings and Precautions (5.10)  ] 
      EXCERPT:   Adverse reactions reported most often include neutropenia, febrile neutropenia, fever, alopecia, nausea, vomiting, and diarrhea. (  6.1  )
 

 To report SUSPECTED ADVERSE REACTIONS, contact Baxter Healthcare at 1-866-888-2472 or FDA at 1-800-FDA-1088 or    www.fda.gov/medwatch    .

 

  6.1 Common Adverse Reactions

    Hematopoietic system:  

 Neutropenia occurs in patients treated with cyclophosphamide. The degree of neutropenia is particularly important because it correlates with a reduction in resistance to infections. Fever without documented infection has been reported in neutropenic patients.

   Gastrointestinal system:  

 Nausea and vomiting occur with cyclophosphamide therapy. Anorexia and, less frequently, abdominal discomfort or pain and diarrhea may occur. There are isolated reports of hemorrhagic colitis, oral mucosal ulceration and jaundice occurring during therapy.

   Skin and its structures:  

 Alopecia occurs in patients treated with cyclophosphamide. Skin rash occurs occasionally in patients receiving the drug. Pigmentation of the skin and changes in nails can occur.

   6.2 Postmarketing Experience

  The following adverse reactions have been identified from clinical trials or post-marketing surveillance. Because they are reported from a population from unknown size, precise estimates of frequency cannot be made.

   Cardiac:  cardiac arrest, ventricular fibrillation, ventricular tachycardia, cardiogenic shock, pericardial effusion (progressing to cardiac tamponade), myocardial hemorrhage, myocardial infarction, cardiac failure (including fatal outcomes), cardiomyopathy, myocarditis, pericarditis, carditis, atrial fibrillation, supraventricular arrhythmia, ventricular arrhythmia, bradycardia, tachycardia, palpitations, QT prolongation.

   Congenital, Familial and Genetic  : intra-uterine death, fetal malformation, fetal growth retardation, fetal toxicity (including myelosuppression, gastroenteritis).

   Ear and Labyrinth:  deafness, hearing impaired, tinnitus.

   Endocrine:  water intoxication.

   Eye:  visual impairment, conjunctivitis, lacrimation.

   Gastrointestinal:  gastrointestinal hemorrhage, acute pancreatitis, colitis, enteritis, cecitis, stomatitis, constipation, parotid gland inflammation.

   General Disorders and Administrative Site Conditions:  multiorgan failure, general physical deterioration, influenza-like illness, injection/infusion site reactions (thrombosis, necrosis, phlebitis, inflammation, pain, swelling, erythema), pyrexia, edema, chest pain, mucosal inflammation, asthenia, pain, chills, fatigue, malaise, headache.

   Hematologic:  myelosuppression, bone marrow failure, disseminated intravascular coagulation and hemolytic uremic syndrome (with thrombotic microangiopathy).

   Hepatic:  veno-occlusive liver disease, cholestatic hepatitis, cytolytic hepatitis, hepatitis, cholestasis; hepatotoxicity with hepatic failure, hepatic encephalopathy, ascites, hepatomegaly, blood bilirubin increased, hepatic function abnormal, hepatic enzymes increased.

   Immune:  immunosuppression, anaphylactic shock and hypersensitivity reaction.

   Infections:  The following manifestations have been associated with myelosuppression and immunosuppression caused by cyclophosphamide: increased risk for and severity of pneumonias (including fatal outcomes), other bacterial, fungal, viral, protozoal and, parasitic infections; reactivation of latent infections, (including viral hepatitis, tuberculosis),  Pneumocystis jiroveci  , herpes zoster,  Strongyloides  , sepsis and septic shock.

   Investigations:  blood lactate dehydrogenase increased, C-reactive protein increased.

   Metabolism and Nutrition:  hyponatremia, fluid retention, blood glucose increased, blood glucose decreased.

   Musculoskeletal and Connective Tissue  : rhabdomyolysis, scleroderma, muscle spasms, myalgia, arthralgia.

   Neoplasms:  acute leukemia, myelodysplastic syndrome, lymphoma, sarcomas, renal cell carcinoma, renal pelvis cancer, bladder cancer, ureteric cancer, thyroid cancer.

   Nervous System:  encephalopathy, convulsion, dizziness, neurotoxicity has been reported and manifested as reversible posterior leukoencephalopathy syndrome, myelopathy, peripheral neuropathy, polyneuropathy, neuralgia, dysesthesia, hypoesthesia, paresthesia, tremor, dysgeusia, hypogeusia, parosmia.

   Pregnancy:  premature labor.

   Psychiatric:  confusional state.

   Renal and Urinary:  renal failure, renal tubular disorder, renal impairment, nephropathy toxic, hemorrhagic cystitis, bladder necrosis, cystitis ulcerative, bladder contracture, hematuria, nephrogenic diabetes insipidus, atypical urinary bladder epithelial cells.

   Reproductive System:  infertility, ovarian failure, ovarian disorder, amenorrhea, oligomenorrhea, testicular atrophy, azoospermia, oligospermia.

   Respiratory:  pulmonary veno-occlusive disease, acute respiratory distress syndrome, interstitial lung disease as manifested by respiratory failure (including fatal outcomes), obliterative bronchiolitis, organizing pneumonia, alveolitis allergic, pneumonitis, pulmonary hemorrhage; respiratory distress, pulmonary hypertension, pulmonary edema, pleural effusion, bronchospasm, dyspnea, hypoxia, cough, nasal congestion, nasal discomfort, oropharyngeal pain, rhinorrhea.

   Skin and Subcutaneous Tissue:  toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme, palmar-plantar erythrodysesthesia syndrome, radiation recall dermatitis, toxic skin eruption, urticaria, dermatitis, blister, pruritus, erythema, nail disorder, facial swelling, hyperhidrosis.

   Tumor lysis syndrome  :    like other cytotoxic drugs, cyclophosphamide may induce tumor-lysis syndrome and hyperuricemia in patients with rapidly growing tumors.

   Vascular:  pulmonary embolism, venous thrombosis, vasculitis, peripheral ischemia, hypertension, hypotension, flushing, hot flush.

</Section>
    <Section id="S2" name="warnings and precautions">   5 WARNINGS AND PRECAUTIONS

   EXCERPT:    *    Myelosuppression, Immunosuppression, Bone Marrow Failure and Infections - Severe immunosuppression may lead to serious and sometimes fatal infections. Close hematological monitoring is required. (  5.1  ) 
 *    Urinary Tract and Renal Toxicity - Hemorrhagic cystitis, pyelitis, ureteritis, and hematuria can occur. Exclude or correct any urinary tract obstructions prior to treatment. (  5.2  ) 
 *    Cardiotoxicity - Myocarditis, myopericarditis, pericardial effusion, arrythmias and congestive heart failure, which may be fatal, have been reported. Monitor patients, especially those with risk factors for cardiotoxicity or pre-existing cardiac disease. (  5.3  ) 
 *    Pulmonary Toxicity - Pneumonitis, pulmonary fibrosis and pulmonary veno-occlusive disease leading to respiratory failure may occur. Monitor patients for signs and symptoms of pulmonary toxicity. (  5.4  ) 
 *    Secondary malignancies(  5.5  ) 
 *    Veno-occlusive Liver Disease - Fatal outcome can occur. (  5.6  ) 
 *    Embryo-Fetal Toxicity - Can cause fetal harm. Advise female patients of reproductive potential to avoid pregnancy. (  5.7  ,  8.1  ,  8.6  ) 
    
 

   5.1 Myelosuppression, Immunosuppression, Bone Marrow Failure and Infections

  Cyclophosphamide can cause myelosuppression (leukopenia, neutropenia, thrombocytopenia and anemia), bone marrow failure, and severe immunosuppression which may lead to serious and sometimes fatal infections, including sepsis and septic shock. Latent infections can be reactivated [see  Adverse Reactions (6.2)  ].

 Antimicrobial prophylaxis may be indicated in certain cases of neutropenia at the discretion of the managing physician. In case of neutropenic fever, antibiotic therapy is indicated. Antimycotics and/or antivirals may also be indicated.

 Monitoring of complete blood counts is essential during cyclophosphamide treatment so that the dose can be adjusted, if needed. Cyclophosphamide should not be administered to patients with neutrophils &lt;=1,500/mm  3  and platelets &lt; 50,000/mm  3  . Cyclophosphamide treatment may not be indicated, or should be interrupted, or the dose reduced, in patients who have or who develop a serious infection. G-CSF may be administered to reduce the risks of neutropenia complications associated with cyclophosphamide use. Primary and secondary prophylaxis with G-CSF should be considered in all patients considered to be at increased risk for neutropenia complications. The nadirs of the reduction in leukocyte count and thrombocyte count are usually reached in weeks 1 and 2 of treatment. Peripheral blood cell counts are expected to normalize after approximately 20 days. Bone marrow failure has been reported. Severe myelosuppression may be expected particularly in patients pretreated with and/or receiving concomitant chemotherapy and/or radiation therapy.

    5.2 Urinary Tract and Renal Toxicity

  Hemorrhagic cystitis, pyelitis, ureteritis, and hematuria have been reported with cyclophosphamide. Medical and/or surgical supportive treatment may be required to treat protracted cases of severe hemorrhagic cystitis. Discontinue cyclophosphamide therapy in case of severe hemorrhagic cystitis. Urotoxicity (bladder ulceration, necrosis, fibrosis, contracture and secondary cancer) may require interruption of cyclophosphamide treatment or cystectomy. Urotoxicity can be fatal. Urotoxicity can occur with short-term or long-term use of cyclophosphamide.

 Before starting treatment, exclude or correct any urinary tract obstructions [see  Contraindications (4)  ]. Urinary sediment should be checked regularly for the presence of erythrocytes and other signs of urotoxicity and/or nephrotoxicity. Cyclophosphamide should be used with caution, if at all, in patients with active urinary tract infections. Aggressive hydration with forced diuresis and frequent bladder emptying can reduce the frequency and severity of bladder toxicity. Mesna has been used to prevent severe bladder toxicity.

    5.3 Cardiotoxicity

  Myocarditis, myopericarditis, pericardial effusion including cardiac tamponade, and congestive heart failure, which may be fatal, have been reported with cyclophosphamide therapy

 Supraventricular arrhythmias (including atrial fibrillation and flutter) and ventricular arrhythmias (including severe QT prolongation associated with ventricular tachyarrhythmia) have been reported after treatment with regimens that included cyclophosphamide.

 The risk of cardiotoxicity may be increased with high doses of cyclophosphamide, in patients with advanced age, and in patients with previous radiation treatment to the cardiac region and/or previous or concomitant treatment with other cardiotoxic agents.

 Particular caution is necessary in patients with risk factors for cardiotoxicity and in patients with pre-existing cardiac disease.

 Monitor patients with risk factors for cardiotoxicity and with pre-existing cardiac disease.

    5.4 Pulmonary Toxicity

  Pneumonitis, pulmonary fibrosis, pulmonary veno-occlusive disease and other forms of pulmonary toxicity leading to respiratory failure have been reported during and following treatment with cyclophosphamide. Late onset pneumonitis (greater than 6 months after start of cyclophosphamide) appears to be associated with increased mortality. Pneumonitis may develop years after treatment with cyclophosphamide.

 Monitor patients for signs and symptoms of pulmonary toxicity.

    5.5 Secondary Malignancies

  Cyclophosphamide is genotoxic [see  Nonclinical Toxicology (13.1)  ]. Secondary malignancies (urinary tract cancer, myelodysplasia, acute leukemias, lymphomas, thyroid cancer, and sarcomas) have been reported in patients treated with cyclophosphamide-containing regimens .  The risk of bladder cancer may be reduced by prevention of hemorrhagic cystitis.

    5.6 Veno-occlusive Liver Disease

  Veno-occlusive liver disease (VOD) including fatal outcome has been reported in patients receiving cyclophosphamide-containing regimens. A cytoreductive regimen in preparation for bone marrow transplantation that consists of cyclophosphamide in combination with whole-body irradiation, busulfan, or other agents has been identified as a major risk factor. VOD has also been reported to develop gradually in patients receiving long-term low-dose immunosuppressive doses of cyclophosphamide. Other risk factors predisposing to the development of VOD include preexisting disturbances of hepatic function, previous radiation therapy of the abdomen, and a low performance status.

    5.7 Embryo-Fetal Toxicity

  Cyclophosphamide can cause fetal harm when administered to a pregnant woman [see  Use in Specific Populations (8.1)  ]. Exposure to cyclophosphamide during pregnancy may cause birth defects, miscarriage, fetal growth retardation, and fetotoxic effects in the newborn. Cyclophosphamide is teratogenic and embryo-fetal toxic in mice, rats, rabbits and monkeys.

 Advise female patients of reproductive potential to avoid becoming pregnant and to use highly effective contraception during treatment and for up to 1 year after completion of therapy [see  Use in Specific Populations (8.6)  ].

    5.8 Infertility

  Male and female reproductive function and fertility may be impaired in patients being treated with cyclophosphamide. Cyclophosphamide interferes with oogenesis and spermatogenesis. It may cause sterility in both sexes. Development of sterility appears to depend on the dose of cyclophosphamide, duration of therapy, and the state of gonadal function at the time of treatment. Cyclophosphamide-induced sterility may be irreversible in some patients. Advise patients on the potential risks for infertility [see  Use in Specific Populations (8.4  and  8.6  )].

    5.9 Impairment of Wound Healing

  Cyclophosphamide may interfere with normal wound healing.

    5.10 Hyponatremia

  Hyponatremia associated with increased total body water, acute water intoxication, and a syndrome resembling SIADH (syndrome of inappropriate secretion of antidiuretic hormone), which may be fatal, has been reported.

</Section>
  </Text>
  <IgnoredRegions>
    <IgnoredRegion len="19" name="heading" section="S1" start="2" />
    <IgnoredRegion len="26" name="heading" section="S2" start="3" />
    <IgnoredRegion len="1163" name="excerpt" section="S2" start="33" />
    <IgnoredRegion len="297" name="excerpt" section="S1" start="982" />
    <IgnoredRegion len="75" name="heading" section="S2" start="1203" />
    <IgnoredRegion len="28" name="heading" section="S1" start="1283" />
    <IgnoredRegion len="28" name="heading" section="S1" start="2106" />
    <IgnoredRegion len="36" name="heading" section="S2" start="2896" />
    <IgnoredRegion len="18" name="heading" section="S2" start="4033" />
    <IgnoredRegion len="22" name="heading" section="S2" start="4989" />
    <IgnoredRegion len="26" name="heading" section="S2" start="5492" />
    <IgnoredRegion len="32" name="heading" section="S2" start="5882" />
    <IgnoredRegion len="25" name="heading" section="S2" start="6598" />
    <IgnoredRegion len="15" name="heading" section="S2" start="7221" />
    <IgnoredRegion len="31" name="heading" section="S2" start="7803" />
    <IgnoredRegion len="17" name="heading" section="S2" start="7901" />
  </IgnoredRegions>
  <Mentions>
    <Mention id="M49" len="16" reason="from_drug_use" section="S1" start="128" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Drug hypersensitivity" meddra_llt_id="10013700" meddra_pt="Drug hypersensitivity" meddra_pt_id="10013700" />
      <Normalization meddra_pt="Hypersensitivity" meddra_pt_id="10020751" />
    </Mention>
    <Mention id="M50" len="16" reason="from_drug_use" section="S1" start="183" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myelosuppression" meddra_llt_id="10028584" meddra_pt="Bone marrow failure" meddra_pt_id="10065553" />
    </Mention>
    <Mention id="M51" len="17" reason="from_drug_use" section="S1" start="201" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Immunosuppression" meddra_llt_id="10062016" meddra_pt="Immunosuppression" meddra_pt_id="10062016" />
    </Mention>
    <Mention id="M52" len="19" reason="from_drug_use" section="S1" start="220" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Bone marrow failure" meddra_llt_id="10065553" meddra_pt="Bone marrow failure" meddra_pt_id="10065553" />
    </Mention>
    <Mention id="M53" len="10" reason="from_drug_use" section="S1" start="245" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infection" meddra_llt_id="10021789" meddra_pt="Infection" meddra_pt_id="10021789" />
    </Mention>
    <Mention id="M54" len="13,8" reason="from_drug_use" section="S1" start="303,327" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Urinary bladder toxicity" meddra_llt_id="10072996" meddra_pt="Urinary bladder toxicity" meddra_pt_id="10072996" />
    </Mention>
    <Mention id="M55" len="14" reason="from_drug_use" section="S1" start="321" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Toxicity renal" meddra_llt_id="10044258" meddra_pt="Nephropathy toxic" meddra_pt_id="10029155" />
    </Mention>
    <Mention id="M56" len="14" reason="from_drug_use" section="S1" start="383" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cardiotoxicity" meddra_llt_id="10048610" meddra_pt="Cardiotoxicity" meddra_pt_id="10048610" />
    </Mention>
    <Mention id="M57" len="18" reason="from_drug_use" section="S1" start="445" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pulmonary toxicity" meddra_llt_id="10061924" meddra_pt="Pulmonary toxicity" meddra_pt_id="10061924" />
    </Mention>
    <Mention id="M58" len="22" reason="from_drug_use" section="S1" start="511" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Second primary malignancy" meddra_llt_id="10039801" meddra_pt="Second primary malignancy" meddra_pt_id="10039801" />
    </Mention>
    <Mention id="M59" len="28" reason="from_drug_use" section="S1" start="581" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Veno-occlusive liver damage" meddra_llt_id="10047207" meddra_pt="Venoocclusive liver disease" meddra_pt_id="10047216" />
    </Mention>
    <Mention id="M60" len="21" reason="from_drug_use" section="S1" start="657" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Teratogenicity" meddra_llt_id="10043275" meddra_pt="Teratogenicity" meddra_pt_id="10043275" />
      <Normalization meddra_pt="Foetal damage" meddra_pt_id="10016852" />
      <Normalization meddra_pt="Maternal drugs affecting foetus" meddra_pt_id="10026923" />
    </Mention>
    <Mention id="M61" len="28" reason="from_drug_use" section="S1" start="726" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Reproductive toxicity" meddra_llt_id="10074268" meddra_pt="Reproductive toxicity" meddra_pt_id="10074268" />
      <Normalization meddra_pt="Reproductive tract disorder" meddra_pt_id="10061483" />
    </Mention>
    <Mention id="M62" len="22" reason="from_drug_use" section="S1" start="852" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Healing impaired" meddra_llt_id="10019239" meddra_pt="Impaired healing" meddra_pt_id="10021519" />
    </Mention>
    <Mention id="M63" len="12" reason="from_drug_use" section="S1" start="922" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hyponatremia" meddra_llt_id="10021038" meddra_pt="Hyponatraemia" meddra_pt_id="10021036" />
    </Mention>
    <Mention id="M64" len="11" reason="from_drug_use" section="S1" start="1343" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Neutropenia" meddra_llt_id="10029354" meddra_pt="Neutropenia" meddra_pt_id="10029354" />
    </Mention>
    <Mention id="M2" len="11" reason="AE_only_as_instruction" section="S1" start="1419" type="NonOSE_AE">
      <Normalization meddra_llt="Neutropenia" meddra_llt_id="10029354" meddra_pt="Neutropenia" meddra_pt_id="10029354" />
    </Mention>
    <Mention id="M45" len="37" reason="manifestation_or_complication" section="S1" start="1486" type="NonOSE_AE">
      <Normalization meddra_llt="Increased susceptibility to infections NOS" meddra_llt_id="10021686" meddra_pt="Infection susceptibility increased" meddra_pt_id="10021866" />
    </Mention>
    <Mention id="M48" len="5" reason="AE_only_as_instruction" section="S1" start="1525" type="NonOSE_AE">
      <Normalization meddra_llt="Fever" meddra_llt_id="10016558" meddra_pt="Pyrexia" meddra_pt_id="10037660" />
    </Mention>
    <Mention id="M3" len="9" reason="negation" section="S1" start="1550" type="NonOSE_AE">
      <Normalization meddra_llt="Infection" meddra_llt_id="10021789" meddra_pt="Infection" meddra_pt_id="10021789" />
    </Mention>
    <Mention id="M46" len="11" reason="AE_only_as_instruction" section="S1" start="1581" type="NonOSE_AE">
      <Normalization meddra_llt="Neutropenic fever" meddra_llt_id="10051312" meddra_pt="Febrile neutropenia" meddra_pt_id="10016288" />
    </Mention>
    <Mention id="M65" len="6" reason="from_drug_use" section="S1" start="1636" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Nausea" meddra_llt_id="10028813" meddra_pt="Nausea" meddra_pt_id="10028813" />
    </Mention>
    <Mention id="M66" len="8" reason="from_drug_use" section="S1" start="1647" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Vomiting" meddra_llt_id="10047700" meddra_pt="Vomiting" meddra_pt_id="10047700" />
    </Mention>
    <Mention id="M67" len="8" reason="from_drug_use" section="S1" start="1693" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Anorexia" meddra_llt_id="10002646" meddra_pt="Decreased appetite" meddra_pt_id="10061428" />
    </Mention>
    <Mention id="M68" len="20" reason="from_drug_use" section="S1" start="1724" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Discomfort abdominal" meddra_llt_id="10013084" meddra_pt="Abdominal discomfort" meddra_pt_id="10000059" />
    </Mention>
    <Mention id="M69" len="9,4" reason="from_drug_use" section="S1" start="1724,1748" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pain abdominal" meddra_llt_id="10033374" meddra_pt="Abdominal pain" meddra_pt_id="10000081" />
    </Mention>
    <Mention id="M70" len="8" reason="from_drug_use" section="S1" start="1757" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Diarrhea" meddra_llt_id="10012727" meddra_pt="Diarrhoea" meddra_pt_id="10012735" />
    </Mention>
    <Mention id="M71" len="19" reason="from_drug_use" section="S1" start="1807" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Colitis hemorrhagic" meddra_llt_id="10009893" meddra_pt="Enterocolitis haemorrhagic" meddra_pt_id="10014896" />
    </Mention>
    <Mention id="M72" len="23" reason="from_drug_use" section="S1" start="1828" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Oral ulceration" meddra_llt_id="10031027" meddra_pt="Mouth ulceration" meddra_pt_id="10028034" />
    </Mention>
    <Mention id="M73" len="8" reason="from_drug_use" section="S1" start="1856" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Jaundice" meddra_llt_id="10023126" meddra_pt="Jaundice" meddra_pt_id="10023126" />
    </Mention>
    <Mention id="M74" len="8" reason="from_drug_use" section="S1" start="1924" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Alopecia" meddra_llt_id="10001760" meddra_pt="Alopecia" meddra_pt_id="10001760" />
    </Mention>
    <Mention id="M75" len="9" reason="from_drug_use" section="S1" start="1983" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Skin rash" meddra_llt_id="10040913" meddra_pt="Rash" meddra_pt_id="10037844" />
    </Mention>
    <Mention id="M76" len="24" reason="from_drug_use" section="S1" start="2045" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pigmentation skin" meddra_llt_id="10035028" meddra_pt="Pigmentation disorder" meddra_pt_id="10062080" />
    </Mention>
    <Mention id="M77" len="12,16" reason="from_drug_use" section="S1" start="2045,2074" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Nail pigmentation" meddra_llt_id="10058455" meddra_pt="Nail pigmentation" meddra_pt_id="10058455" />
    </Mention>
    <Mention id="M4" len="7" reason="general_term" section="S1" start="2358" type="NonOSE_AE">
      <Normalization meddra_llt="Cardiac disorder" meddra_llt_id="10061024" meddra_pt="Cardiac disorder" meddra_pt_id="10061024" />
    </Mention>
    <Mention id="M78" len="14" reason="from_drug_use" section="S1" start="2368" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Arrest cardiac" meddra_llt_id="10003109" meddra_pt="Cardiac arrest" meddra_pt_id="10007515" />
    </Mention>
    <Mention id="M79" len="24" reason="from_drug_use" section="S1" start="2384" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Ventricular fibrillation" meddra_llt_id="10047290" meddra_pt="Ventricular fibrillation" meddra_pt_id="10047290" />
    </Mention>
    <Mention id="M80" len="23" reason="from_drug_use" section="S1" start="2410" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Tachycardia ventricular" meddra_llt_id="10043085" meddra_pt="Ventricular tachycardia" meddra_pt_id="10047302" />
    </Mention>
    <Mention id="M81" len="17" reason="from_drug_use" section="S1" start="2435" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cardiogenic shock" meddra_llt_id="10007625" meddra_pt="Cardiogenic shock" meddra_pt_id="10007625" />
    </Mention>
    <Mention id="M82" len="20" reason="from_drug_use" section="S1" start="2454" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Effusion pericardial" meddra_llt_id="10014311" meddra_pt="Pericardial effusion" meddra_pt_id="10034474" />
    </Mention>
    <Mention id="M83" len="17" reason="from_drug_use" section="S1" start="2491" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cardiac tamponade" meddra_llt_id="10007610" meddra_pt="Cardiac tamponade" meddra_pt_id="10007610" />
    </Mention>
    <Mention id="M84" len="21" reason="from_drug_use" section="S1" start="2511" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myocardial hemorrhage" meddra_llt_id="10055308" meddra_pt="Myocardial haemorrhage" meddra_pt_id="10048849" />
    </Mention>
    <Mention id="M85" len="21" reason="from_drug_use" section="S1" start="2534" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myocardial infarction" meddra_llt_id="10028596" meddra_pt="Myocardial infarction" meddra_pt_id="10028596" />
    </Mention>
    <Mention id="M86" len="15" reason="from_drug_use" section="S1" start="2557" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cardiac failure" meddra_llt_id="10007554" meddra_pt="Cardiac failure" meddra_pt_id="10007554" />
    </Mention>
    <Mention id="M27" len="5" reason="general_term" section="S1" start="2584" type="NonOSE_AE">
      <Normalization meddra_llt="Death" meddra_llt_id="10011906" meddra_pt="Death" meddra_pt_id="10011906" />
    </Mention>
    <Mention id="M87" len="14" reason="from_drug_use" section="S1" start="2601" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cardiomyopathy" meddra_llt_id="10007636" meddra_pt="Cardiomyopathy" meddra_pt_id="10007636" />
    </Mention>
    <Mention id="M88" len="11" reason="from_drug_use" section="S1" start="2617" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myocarditis" meddra_llt_id="10028606" meddra_pt="Myocarditis" meddra_pt_id="10028606" />
    </Mention>
    <Mention id="M89" len="12" reason="from_drug_use" section="S1" start="2630" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pericarditis" meddra_llt_id="10034484" meddra_pt="Pericarditis" meddra_pt_id="10034484" />
    </Mention>
    <Mention id="M90" len="8" reason="from_drug_use" section="S1" start="2644" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Carditis" meddra_llt_id="10062746" meddra_pt="Carditis" meddra_pt_id="10062746" />
    </Mention>
    <Mention id="M91" len="19" reason="from_drug_use" section="S1" start="2654" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Atrial fibrillation" meddra_llt_id="10003658" meddra_pt="Atrial fibrillation" meddra_pt_id="10003658" />
    </Mention>
    <Mention id="M92" len="27" reason="from_drug_use" section="S1" start="2675" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Arrhythmia supraventricular" meddra_llt_id="10003130" meddra_pt="Arrhythmia supraventricular" meddra_pt_id="10003130" />
    </Mention>
    <Mention id="M93" len="22" reason="from_drug_use" section="S1" start="2704" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Arrhythmia ventricular" meddra_llt_id="10003131" meddra_pt="Ventricular arrhythmia" meddra_pt_id="10047281" />
    </Mention>
    <Mention id="M94" len="11" reason="from_drug_use" section="S1" start="2728" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Bradycardia" meddra_llt_id="10006093" meddra_pt="Bradycardia" meddra_pt_id="10006093" />
    </Mention>
    <Mention id="M95" len="11" reason="from_drug_use" section="S1" start="2741" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Tachycardia" meddra_llt_id="10043071" meddra_pt="Tachycardia" meddra_pt_id="10043071" />
    </Mention>
    <Mention id="M97" len="12" reason="from_drug_use" section="S1" start="2754" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Palpitation" meddra_llt_id="10033556" meddra_pt="Palpitations" meddra_pt_id="10033557" />
    </Mention>
    <Mention id="M96" len="15" reason="from_drug_use" section="S1" start="2768" type="OSE_Labeled_AE">
      <Normalization meddra_llt="QT increased" meddra_llt_id="10037700" meddra_pt="Electrocardiogram QT prolonged" meddra_pt_id="10014387" />
    </Mention>
    <Mention id="M5" len="32" reason="general_term" section="S1" start="2789" type="NonOSE_AE">
      <Normalization meddra_llt="Congenital" meddra_llt_id="10010307" meddra_pt="Congenital anomaly" meddra_pt_id="10010356" />
      <Normalization meddra_pt="Congenital anomaly in offspring" meddra_pt_id="10063726" />
    </Mention>
    <Mention id="M98" len="19" reason="from_drug_use" section="S1" start="2825" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Intra-uterine death" meddra_llt_id="10022747" meddra_pt="Foetal death" meddra_pt_id="10055690" />
    </Mention>
    <Mention id="M99" len="18" reason="from_drug_use" section="S1" start="2846" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fetal malformation" meddra_llt_id="10060920" meddra_pt="Foetal malformation" meddra_pt_id="10060919" />
    </Mention>
    <Mention id="M100" len="24" reason="from_drug_use" section="S1" start="2866" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fetal growth retardation" meddra_llt_id="10054746" meddra_pt="Foetal growth restriction" meddra_pt_id="10070531" />
    </Mention>
    <Mention id="M101" len="14" reason="from_drug_use" section="S1" start="2892" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Teratogenicity" meddra_llt_id="10043275" meddra_pt="Teratogenicity" meddra_pt_id="10043275" />
      <Normalization meddra_pt="Foetal damage" meddra_pt_id="10016852" />
      <Normalization meddra_pt="Maternal drugs affecting foetus" meddra_pt_id="10026923" />
    </Mention>
    <Mention id="M102" len="16" reason="from_drug_use" section="S1" start="2918" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myelosuppression" meddra_llt_id="10028584" meddra_pt="Bone marrow failure" meddra_pt_id="10065553" />
    </Mention>
    <Mention id="M104" len="15" reason="from_drug_use" section="S1" start="2936" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Gastroenteritis" meddra_llt_id="10017888" meddra_pt="Gastroenteritis" meddra_pt_id="10017888" />
    </Mention>
    <Mention id="M6" len="17" reason="general_term" section="S1" start="2958" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder ear" meddra_llt_id="10013214" meddra_pt="Ear disorder" meddra_pt_id="10014004" />
    </Mention>
    <Mention id="M103" len="8" reason="from_drug_use" section="S1" start="2978" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Deafness" meddra_llt_id="10011878" meddra_pt="Deafness" meddra_pt_id="10011878" />
    </Mention>
    <Mention id="M105" len="16" reason="from_drug_use" section="S1" start="2988" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hearing impaired" meddra_llt_id="10019245" meddra_pt="Hypoacusis" meddra_pt_id="10048865" />
    </Mention>
    <Mention id="M106" len="8" reason="from_drug_use" section="S1" start="3006" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Tinnitus" meddra_llt_id="10043882" meddra_pt="Tinnitus" meddra_pt_id="10043882" />
    </Mention>
    <Mention id="M7" len="9" reason="general_term" section="S1" start="3020" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder endocrine" meddra_llt_id="10013217" meddra_pt="Endocrine disorder" meddra_pt_id="10014695" />
    </Mention>
    <Mention id="M107" len="18" reason="from_drug_use" section="S1" start="3032" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Water intoxication" meddra_llt_id="10047837" meddra_pt="Water intoxication" meddra_pt_id="10047837" />
    </Mention>
    <Mention id="M8" len="3" reason="general_term" section="S1" start="3056" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder eye" meddra_llt_id="10013221" meddra_pt="Eye disorder" meddra_pt_id="10015916" />
      <Normalization meddra_pt="Ocular toxicity" meddra_pt_id="10061137" />
    </Mention>
    <Mention id="M108" len="17" reason="from_drug_use" section="S1" start="3062" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Visual impairment" meddra_llt_id="10047571" meddra_pt="Visual impairment" meddra_pt_id="10047571" />
    </Mention>
    <Mention id="M109" len="14" reason="from_drug_use" section="S1" start="3081" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Conjunctivitis" meddra_llt_id="10010741" meddra_pt="Conjunctivitis" meddra_pt_id="10010741" />
    </Mention>
    <Mention id="M110" len="11" reason="from_drug_use" section="S1" start="3097" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Lacrimation" meddra_llt_id="10023639" meddra_pt="Lacrimation increased" meddra_pt_id="10023644" />
    </Mention>
    <Mention id="M9" len="16" reason="general_term" section="S1" start="3114" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder gastrointestinal" meddra_llt_id="10013225" meddra_pt="Gastrointestinal disorder" meddra_pt_id="10017944" />
    </Mention>
    <Mention id="M111" len="27" reason="from_drug_use" section="S1" start="3133" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hemorrhage gastrointestinal" meddra_llt_id="10019543" meddra_pt="Gastrointestinal haemorrhage" meddra_pt_id="10017955" />
    </Mention>
    <Mention id="M112" len="18" reason="from_drug_use" section="S1" start="3162" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Acute pancreatitis" meddra_llt_id="10000971" meddra_pt="Pancreatitis acute" meddra_pt_id="10033647" />
    </Mention>
    <Mention id="M113" len="7" reason="from_drug_use" section="S1" start="3182" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Colitis" meddra_llt_id="10009887" meddra_pt="Colitis" meddra_pt_id="10009887" />
    </Mention>
    <Mention id="M114" len="9" reason="from_drug_use" section="S1" start="3191" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Enteritis" meddra_llt_id="10014866" meddra_pt="Enteritis" meddra_pt_id="10014866" />
    </Mention>
    <Mention id="M115" len="7" reason="from_drug_use" section="S1" start="3202" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cecitis" meddra_llt_id="10007859" meddra_pt="Colitis" meddra_pt_id="10009887" />
    </Mention>
    <Mention id="M116" len="10" reason="from_drug_use" section="S1" start="3211" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Stomatitis" meddra_llt_id="10042128" meddra_pt="Stomatitis" meddra_pt_id="10042128" />
    </Mention>
    <Mention id="M117" len="12" reason="from_drug_use" section="S1" start="3223" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Constipation" meddra_llt_id="10010774" meddra_pt="Constipation" meddra_pt_id="10010774" />
    </Mention>
    <Mention id="M118" len="26" reason="from_drug_use" section="S1" start="3237" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Parotid gland inflammation" meddra_llt_id="10067789" meddra_pt="Noninfective sialoadenitis" meddra_pt_id="10075243" />
    </Mention>
    <Mention id="M10" len="52" reason="general_term" section="S1" start="3269" type="NonOSE_AE">
      <Normalization meddra_llt="General symptom" meddra_llt_id="10060891" meddra_pt="General symptom" meddra_pt_id="10060891" />
    </Mention>
    <Mention id="M119" len="18" reason="from_drug_use" section="S1" start="3324" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Multiorgan failure" meddra_llt_id="10028162" meddra_pt="Multiple organ dysfunction syndrome" meddra_pt_id="10077361" />
    </Mention>
    <Mention id="M120" len="30" reason="from_drug_use" section="S1" start="3344" type="OSE_Labeled_AE">
      <Normalization meddra_llt="General physical health deterioration" meddra_llt_id="10049438" meddra_pt="General physical health deterioration" meddra_pt_id="10049438" />
    </Mention>
    <Mention id="M121" len="22" reason="from_drug_use" section="S1" start="3376" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Influenza like illness" meddra_llt_id="10022004" meddra_pt="Influenza like illness" meddra_pt_id="10022004" />
    </Mention>
    <Mention id="M122" len="9,14" reason="from_drug_use" section="S1" start="3400,3419" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Injection site reaction" meddra_llt_id="10022095" meddra_pt="Injection site reaction" meddra_pt_id="10022095" />
    </Mention>
    <Mention id="M124" len="9,14,10" reason="from_drug_use" section="S1" start="3400,3419,3435" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Injection site thrombosis" meddra_llt_id="10022104" meddra_pt="Injection site thrombosis" meddra_pt_id="10022104" />
    </Mention>
    <Mention id="M125" len="9,14,8" reason="from_drug_use" section="S1" start="3400,3419,3447" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Necrosis injection site" meddra_llt_id="10028860" meddra_pt="Injection site necrosis" meddra_pt_id="10022082" />
    </Mention>
    <Mention id="M126" len="9,14,12" reason="from_drug_use" section="S1" start="3400,3419,3468" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Inflammation injection site" meddra_llt_id="10021957" meddra_pt="Injection site inflammation" meddra_pt_id="10022078" />
    </Mention>
    <Mention id="M127" len="9,14,4" reason="from_drug_use" section="S1" start="3400,3419,3482" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Injection site pain" meddra_llt_id="10022086" meddra_pt="Injection site pain" meddra_pt_id="10022086" />
    </Mention>
    <Mention id="M128" len="9,14,8" reason="from_drug_use" section="S1" start="3400,3419,3488" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Injection site swelling" meddra_llt_id="10053425" meddra_pt="Injection site swelling" meddra_pt_id="10053425" />
    </Mention>
    <Mention id="M129" len="9,14,8" reason="from_drug_use" section="S1" start="3400,3419,3498" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Injection site erythema" meddra_llt_id="10022061" meddra_pt="Injection site erythema" meddra_pt_id="10022061" />
    </Mention>
    <Mention id="M266" len="9,4,9" reason="from_drug_use" section="S1" start="3400,3419,3457" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Injection site phlebitis" meddra_llt_id="10022090" meddra_pt="Injection site phlebitis" meddra_pt_id="10022090" />
    </Mention>
    <Mention id="M123" len="23" reason="from_drug_use" section="S1" start="3410" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infusion site reaction" meddra_llt_id="10054996" meddra_pt="Infusion site reaction" meddra_pt_id="10054996" />
    </Mention>
    <Mention id="M264" len="23,10" reason="from_drug_use" section="S1" start="3410,3435" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infusion site thrombosis" meddra_llt_id="10065489" meddra_pt="Infusion site thrombosis" meddra_pt_id="10065489" />
    </Mention>
    <Mention id="M265" len="23,8" reason="from_drug_use" section="S1" start="3410,3447" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infusion site necrosis" meddra_llt_id="10065478" meddra_pt="Infusion site necrosis" meddra_pt_id="10065478" />
    </Mention>
    <Mention id="M267" len="23,9" reason="from_drug_use" section="S1" start="3410,3457" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infusion site phlebitis" meddra_llt_id="10053663" meddra_pt="Infusion site phlebitis" meddra_pt_id="10053663" />
    </Mention>
    <Mention id="M268" len="23,12" reason="from_drug_use" section="S1" start="3410,3468" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infusion site inflammation" meddra_llt_id="10056270" meddra_pt="Infusion site inflammation" meddra_pt_id="10056270" />
    </Mention>
    <Mention id="M269" len="23,4" reason="from_drug_use" section="S1" start="3410,3482" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infusion site pain" meddra_llt_id="10053483" meddra_pt="Infusion site pain" meddra_pt_id="10053483" />
    </Mention>
    <Mention id="M270" len="23,8" reason="from_drug_use" section="S1" start="3410,3488" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infusion site swelling" meddra_llt_id="10053505" meddra_pt="Infusion site swelling" meddra_pt_id="10053505" />
    </Mention>
    <Mention id="M271" len="23,8" reason="from_drug_use" section="S1" start="3410,3498" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infusion site erythema" meddra_llt_id="10048634" meddra_pt="Infusion site erythema" meddra_pt_id="10048634" />
    </Mention>
    <Mention id="M130" len="7" reason="from_drug_use" section="S1" start="3509" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pyrexia" meddra_llt_id="10037660" meddra_pt="Pyrexia" meddra_pt_id="10037660" />
    </Mention>
    <Mention id="M131" len="5" reason="from_drug_use" section="S1" start="3518" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Edema" meddra_llt_id="10014210" meddra_pt="Oedema" meddra_pt_id="10030095" />
    </Mention>
    <Mention id="M132" len="10" reason="from_drug_use" section="S1" start="3525" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pain chest" meddra_llt_id="10033387" meddra_pt="Chest pain" meddra_pt_id="10008479" />
    </Mention>
    <Mention id="M133" len="20" reason="from_drug_use" section="S1" start="3537" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Mucosal inflammation" meddra_llt_id="10028116" meddra_pt="Mucosal inflammation" meddra_pt_id="10028116" />
    </Mention>
    <Mention id="M134" len="8" reason="from_drug_use" section="S1" start="3559" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Asthenia" meddra_llt_id="10003549" meddra_pt="Asthenia" meddra_pt_id="10003549" />
    </Mention>
    <Mention id="M135" len="4" reason="from_drug_use" section="S1" start="3569" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pain" meddra_llt_id="10033371" meddra_pt="Pain" meddra_pt_id="10033371" />
    </Mention>
    <Mention id="M136" len="6" reason="from_drug_use" section="S1" start="3575" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Chills" meddra_llt_id="10008531" meddra_pt="Chills" meddra_pt_id="10008531" />
    </Mention>
    <Mention id="M137" len="7" reason="from_drug_use" section="S1" start="3583" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fatigue" meddra_llt_id="10016256" meddra_pt="Fatigue" meddra_pt_id="10016256" />
    </Mention>
    <Mention id="M138" len="7" reason="from_drug_use" section="S1" start="3592" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Malaise" meddra_llt_id="10025482" meddra_pt="Malaise" meddra_pt_id="10025482" />
    </Mention>
    <Mention id="M139" len="8" reason="from_drug_use" section="S1" start="3601" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Headache" meddra_llt_id="10019211" meddra_pt="Headache" meddra_pt_id="10019211" />
    </Mention>
    <Mention id="M11" len="11" reason="general_term" section="S1" start="3615" type="NonOSE_AE">
      <Normalization meddra_llt="Hematologic disorder" meddra_llt_id="10019426" meddra_pt="Blood disorder" meddra_pt_id="10061590" />
      <Normalization meddra_pt="Haematology test abnormal" meddra_pt_id="10057755" />
    </Mention>
    <Mention id="M140" len="16" reason="from_drug_use" section="S1" start="3629" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myelosuppression" meddra_llt_id="10028584" meddra_pt="Bone marrow failure" meddra_pt_id="10065553" />
    </Mention>
    <Mention id="M141" len="19" reason="from_drug_use" section="S1" start="3647" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Bone marrow failure" meddra_llt_id="10065553" meddra_pt="Bone marrow failure" meddra_pt_id="10065553" />
    </Mention>
    <Mention id="M142" len="38" reason="from_drug_use" section="S1" start="3668" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Disseminated intravascular coagulation" meddra_llt_id="10013442" meddra_pt="Disseminated intravascular coagulation" meddra_pt_id="10013442" />
    </Mention>
    <Mention id="M143" len="25" reason="from_drug_use" section="S1" start="3711" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hemolytic-uremic syndrome" meddra_llt_id="10019516" meddra_pt="Haemolytic uraemic syndrome" meddra_pt_id="10018932" />
    </Mention>
    <Mention id="M144" len="26" reason="from_drug_use" section="S1" start="3743" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Thrombotic microangiopathy" meddra_llt_id="10043645" meddra_pt="Thrombotic microangiopathy" meddra_pt_id="10043645" />
    </Mention>
    <Mention id="M12" len="7" reason="general_term" section="S1" start="3776" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder liver" meddra_llt_id="10013234" meddra_pt="Liver disorder" meddra_pt_id="10024670" />
      <Normalization meddra_pt="Hepatotoxicity" meddra_pt_id="10019851" />
    </Mention>
    <Mention id="M145" len="28" reason="from_drug_use" section="S1" start="3786" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Veno-occlusive liver damage" meddra_llt_id="10047207" meddra_pt="Venoocclusive liver disease" meddra_pt_id="10047216" />
    </Mention>
    <Mention id="M146" len="21" reason="from_drug_use" section="S1" start="3816" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cholestatic hepatitis" meddra_llt_id="10008639" meddra_pt="Hepatitis cholestatic" meddra_pt_id="10019754" />
    </Mention>
    <Mention id="M147" len="19" reason="from_drug_use" section="S1" start="3839" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cytolytic hepatitis" meddra_llt_id="10050904" meddra_pt="Hepatitis" meddra_pt_id="10019717" />
    </Mention>
    <Mention id="M148" len="9" reason="from_drug_use" section="S1" start="3860" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hepatitis" meddra_llt_id="10019717" meddra_pt="Hepatitis" meddra_pt_id="10019717" />
    </Mention>
    <Mention id="M149" len="11" reason="from_drug_use" section="S1" start="3871" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cholestasis" meddra_llt_id="10008635" meddra_pt="Cholestasis" meddra_pt_id="10008635" />
    </Mention>
    <Mention id="M150" len="14" reason="from_drug_use" section="S1" start="3884" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hepatotoxicity" meddra_llt_id="10019851" meddra_pt="Hepatotoxicity" meddra_pt_id="10019851" />
      <Normalization meddra_pt="Liver disorder" meddra_pt_id="10024670" />
    </Mention>
    <Mention id="M151" len="15" reason="from_drug_use" section="S1" start="3904" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hepatic failure" meddra_llt_id="10019663" meddra_pt="Hepatic failure" meddra_pt_id="10019663" />
    </Mention>
    <Mention id="M152" len="22" reason="from_drug_use" section="S1" start="3921" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hepatic encephalopathy" meddra_llt_id="10019660" meddra_pt="Hepatic encephalopathy" meddra_pt_id="10019660" />
    </Mention>
    <Mention id="M153" len="7" reason="from_drug_use" section="S1" start="3945" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Ascites" meddra_llt_id="10003445" meddra_pt="Ascites" meddra_pt_id="10003445" />
    </Mention>
    <Mention id="M154" len="12" reason="from_drug_use" section="S1" start="3954" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hepatomegaly" meddra_llt_id="10019842" meddra_pt="Hepatomegaly" meddra_pt_id="10019842" />
    </Mention>
    <Mention id="M155" len="25" reason="from_drug_use" section="S1" start="3968" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Blood bilirubin increased" meddra_llt_id="10005364" meddra_pt="Blood bilirubin increased" meddra_pt_id="10005364" />
    </Mention>
    <Mention id="M156" len="25" reason="from_drug_use" section="S1" start="3995" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hepatic function abnormal" meddra_llt_id="10019670" meddra_pt="Hepatic function abnormal" meddra_pt_id="10019670" />
    </Mention>
    <Mention id="M157" len="25" reason="from_drug_use" section="S1" start="4022" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hepatic enzymes increased" meddra_llt_id="10019662" meddra_pt="Hepatic enzyme increased" meddra_pt_id="10060795" />
    </Mention>
    <Mention id="M13" len="6" reason="general_term" section="S1" start="4053" type="NonOSE_AE">
      <Normalization meddra_llt="Immune disorder (NOS)" meddra_llt_id="10021418" meddra_pt="Immune system disorder" meddra_pt_id="10021425" />
    </Mention>
    <Mention id="M158" len="17" reason="from_drug_use" section="S1" start="4062" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Immunosuppression" meddra_llt_id="10062016" meddra_pt="Immunosuppression" meddra_pt_id="10062016" />
    </Mention>
    <Mention id="M159" len="18" reason="from_drug_use" section="S1" start="4081" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Anaphylactic shock" meddra_llt_id="10002199" meddra_pt="Anaphylactic shock" meddra_pt_id="10002199" />
    </Mention>
    <Mention id="M160" len="25" reason="from_drug_use" section="S1" start="4104" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hypersensitivity reaction" meddra_llt_id="10020756" meddra_pt="Hypersensitivity" meddra_pt_id="10020751" />
      <Normalization meddra_pt="Drug hypersensitivity" meddra_pt_id="10013700" />
    </Mention>
    <Mention id="M14" len="10" reason="general_term" section="S1" start="4135" type="NonOSE_AE">
      <Normalization meddra_llt="Infection" meddra_llt_id="10021789" meddra_pt="Infection" meddra_pt_id="10021789" />
    </Mention>
    <Mention id="M161" len="16" reason="from_drug_use" section="S1" start="4203" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myelosuppression" meddra_llt_id="10028584" meddra_pt="Bone marrow failure" meddra_pt_id="10065553" />
    </Mention>
    <Mention id="M162" len="17" reason="from_drug_use" section="S1" start="4224" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Immunosuppression" meddra_llt_id="10062016" meddra_pt="Immunosuppression" meddra_pt_id="10062016" />
    </Mention>
    <Mention id="M28" len="10" reason="manifestation_or_complication" section="S1" start="4305" type="NonOSE_AE">
      <Normalization meddra_llt="Pneumonia" meddra_llt_id="10035664" meddra_pt="Pneumonia" meddra_pt_id="10035664" />
    </Mention>
    <Mention id="M29" len="5" reason="general_term" section="S1" start="4327" type="NonOSE_AE">
      <Normalization meddra_llt="Death" meddra_llt_id="10011906" meddra_pt="Death" meddra_pt_id="10011906" />
    </Mention>
    <Mention id="M33" len="9,10" reason="manifestation_or_complication" section="S1" start="4350,4401" type="NonOSE_AE">
      <Normalization meddra_llt="Bacterial infection" meddra_llt_id="10060945" meddra_pt="Bacterial infection" meddra_pt_id="10060945" />
    </Mention>
    <Mention id="M34" len="6,10" reason="manifestation_or_complication" section="S1" start="4361,4401" type="NonOSE_AE">
      <Normalization meddra_llt="Infection fungal" meddra_llt_id="10021814" meddra_pt="Fungal infection" meddra_pt_id="10017533" />
    </Mention>
    <Mention id="M35" len="5,10" reason="manifestation_or_complication" section="S1" start="4369,4401" type="NonOSE_AE">
      <Normalization meddra_llt="Infection viral" meddra_llt_id="10021876" meddra_pt="Viral infection" meddra_pt_id="10047461" />
      <Normalization meddra_pt="Infection reactivation" meddra_pt_id="10070891" />
    </Mention>
    <Mention id="M36" len="9,10" reason="manifestation_or_complication" section="S1" start="4376,4401" type="NonOSE_AE">
      <Normalization meddra_llt="Infection protozoal" meddra_llt_id="10021859" meddra_pt="Infection protozoal" meddra_pt_id="10021859" />
    </Mention>
    <Mention id="M37" len="20" reason="manifestation_or_complication" section="S1" start="4391" type="NonOSE_AE">
      <Normalization meddra_llt="Infection parasitic" meddra_llt_id="10021857" meddra_pt="Infection parasitic" meddra_pt_id="10021857" />
    </Mention>
    <Mention id="M38" len="12,15" reason="manifestation_or_complication" section="S1" start="4413,4459" type="NonOSE_AE">
      <Normalization meddra_llt="Hepatitis viral" meddra_llt_id="10019799" meddra_pt="Hepatitis viral" meddra_pt_id="10019799" />
    </Mention>
    <Mention id="M39" len="12,12" reason="manifestation_or_complication" section="S1" start="4413,4476" type="NonOSE_AE">
      <Normalization meddra_llt="Tuberculosis reactivated" meddra_llt_id="10045025" meddra_pt="Tuberculosis" meddra_pt_id="10044755" />
    </Mention>
    <Mention id="M47" len="33" reason="manifestation_or_complication" section="S1" start="4413" type="NonOSE_AE">
      <Normalization meddra_llt="Infection reactivation" meddra_llt_id="10070891" meddra_pt="Infection reactivation" meddra_pt_id="10070891" />
      <Normalization meddra_pt="Viral infection" meddra_pt_id="10047461" />
    </Mention>
    <Mention id="M41" len="21" reason="manifestation_or_complication" section="S1" start="4492" type="NonOSE_AE">
      <Normalization meddra_llt="Pneumocystis jiroveci infection" meddra_llt_id="10064107" meddra_pt="Pneumocystis jirovecii infection" meddra_pt_id="10073756" />
    </Mention>
    <Mention id="M42" len="13" reason="manifestation_or_complication" section="S1" start="4517" type="NonOSE_AE">
      <Normalization meddra_llt="Herpes zoster" meddra_llt_id="10019974" meddra_pt="Herpes zoster" meddra_pt_id="10019974" />
    </Mention>
    <Mention id="M40" len="13" reason="manifestation_or_complication" section="S1" start="4533" type="NonOSE_AE">
      <Normalization meddra_llt="Strongyloides stercoralis infection" meddra_llt_id="10042253" meddra_pt="Strongyloidiasis" meddra_pt_id="10042254" />
    </Mention>
    <Mention id="M43" len="6" reason="manifestation_or_complication" section="S1" start="4550" type="NonOSE_AE">
      <Normalization meddra_llt="Sepsis" meddra_llt_id="10040047" meddra_pt="Sepsis" meddra_pt_id="10040047" />
    </Mention>
    <Mention id="M44" len="12" reason="manifestation_or_complication" section="S1" start="4561" type="NonOSE_AE">
      <Normalization meddra_llt="Septic shock" meddra_llt_id="10040070" meddra_pt="Septic shock" meddra_pt_id="10040070" />
    </Mention>
    <Mention id="M15" len="14" reason="general_term" section="S1" start="4579" type="NonOSE_AE">
      <Normalization meddra_llt="Investigation" meddra_llt_id="10062026" meddra_pt="Investigation" meddra_pt_id="10062026" />
    </Mention>
    <Mention id="M163" len="37" reason="from_drug_use" section="S1" start="4596" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Blood lactate dehydrogenase increased" meddra_llt_id="10005630" meddra_pt="Blood lactate dehydrogenase increased" meddra_pt_id="10005630" />
    </Mention>
    <Mention id="M164" len="28" reason="from_drug_use" section="S1" start="4635" type="OSE_Labeled_AE">
      <Normalization meddra_llt="C-reactive protein increased" meddra_llt_id="10006825" meddra_pt="C-reactive protein increased" meddra_pt_id="10006825" />
    </Mention>
    <Mention id="M16" len="24" reason="general_term" section="S1" start="4669" type="NonOSE_AE">
      <Normalization meddra_llt="Symptoms concerning nutrition, metabolism, and development" meddra_llt_id="10042757" meddra_pt="Metabolic disorder" meddra_pt_id="10058097" />
    </Mention>
    <Mention id="M165" len="12" reason="from_drug_use" section="S1" start="4696" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hyponatremia" meddra_llt_id="10021038" meddra_pt="Hyponatraemia" meddra_pt_id="10021036" />
    </Mention>
    <Mention id="M166" len="15" reason="from_drug_use" section="S1" start="4710" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fluid retention" meddra_llt_id="10016807" meddra_pt="Fluid retention" meddra_pt_id="10016807" />
    </Mention>
    <Mention id="M167" len="23" reason="from_drug_use" section="S1" start="4727" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Blood glucose increased" meddra_llt_id="10005557" meddra_pt="Blood glucose increased" meddra_pt_id="10005557" />
      <Normalization meddra_pt="Impaired fasting glucose" meddra_pt_id="10056997" />
    </Mention>
    <Mention id="M168" len="23" reason="from_drug_use" section="S1" start="4752" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Blood glucose decreased" meddra_llt_id="10005555" meddra_pt="Blood glucose decreased" meddra_pt_id="10005555" />
    </Mention>
    <Mention id="M17" len="37" reason="general_term" section="S1" start="4781" type="NonOSE_AE">
      <Normalization meddra_llt="Musculoskeletal disorder" meddra_llt_id="10048592" meddra_pt="Musculoskeletal disorder" meddra_pt_id="10048592" />
    </Mention>
    <Mention id="M169" len="14" reason="from_drug_use" section="S1" start="4822" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Rhabdomyolysis" meddra_llt_id="10039020" meddra_pt="Rhabdomyolysis" meddra_pt_id="10039020" />
    </Mention>
    <Mention id="M170" len="11" reason="from_drug_use" section="S1" start="4838" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Scleroderma" meddra_llt_id="10039710" meddra_pt="Scleroderma" meddra_pt_id="10039710" />
    </Mention>
    <Mention id="M171" len="13" reason="from_drug_use" section="S1" start="4851" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Muscle spasms" meddra_llt_id="10028334" meddra_pt="Muscle spasms" meddra_pt_id="10028334" />
    </Mention>
    <Mention id="M172" len="7" reason="from_drug_use" section="S1" start="4866" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myalgia" meddra_llt_id="10028411" meddra_pt="Myalgia" meddra_pt_id="10028411" />
    </Mention>
    <Mention id="M173" len="10" reason="from_drug_use" section="S1" start="4875" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Arthralgia" meddra_llt_id="10003239" meddra_pt="Arthralgia" meddra_pt_id="10003239" />
    </Mention>
    <Mention id="M18" len="9" reason="general_term" section="S1" start="4891" type="NonOSE_AE">
      <Normalization meddra_llt="Neoplasm" meddra_llt_id="10028980" meddra_pt="Neoplasm" meddra_pt_id="10028980" />
    </Mention>
    <Mention id="M174" len="14" reason="from_drug_use" section="S1" start="4903" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Acute leukemia" meddra_llt_id="10000835" meddra_pt="Acute leukaemia" meddra_pt_id="10000830" />
    </Mention>
    <Mention id="M175" len="24" reason="from_drug_use" section="S1" start="4919" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myelodysplastic syndrome" meddra_llt_id="10028533" meddra_pt="Myelodysplastic syndrome" meddra_pt_id="10028533" />
    </Mention>
    <Mention id="M176" len="8" reason="from_drug_use" section="S1" start="4945" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Lymphoma" meddra_llt_id="10025310" meddra_pt="Lymphoma" meddra_pt_id="10025310" />
    </Mention>
    <Mention id="M177" len="8" reason="from_drug_use" section="S1" start="4955" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Sarcoma" meddra_llt_id="10039491" meddra_pt="Sarcoma" meddra_pt_id="10039491" />
    </Mention>
    <Mention id="M178" len="20" reason="from_drug_use" section="S1" start="4965" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Renal cell carcinoma" meddra_llt_id="10067946" meddra_pt="Renal cell carcinoma" meddra_pt_id="10067946" />
    </Mention>
    <Mention id="M179" len="19" reason="from_drug_use" section="S1" start="4987" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Renal pelvis cancer NOS" meddra_llt_id="10038517" meddra_pt="Malignant neoplasm of renal pelvis" meddra_pt_id="10026426" />
    </Mention>
    <Mention id="M180" len="14" reason="from_drug_use" section="S1" start="5008" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Bladder cancer" meddra_llt_id="10005003" meddra_pt="Bladder cancer" meddra_pt_id="10005003" />
    </Mention>
    <Mention id="M181" len="15" reason="from_drug_use" section="S1" start="5024" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Ureteric cancer" meddra_llt_id="10046392" meddra_pt="Ureteric cancer" meddra_pt_id="10046392" />
    </Mention>
    <Mention id="M182" len="14" reason="from_drug_use" section="S1" start="5041" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Thyroid cancer" meddra_llt_id="10066474" meddra_pt="Thyroid cancer" meddra_pt_id="10066474" />
    </Mention>
    <Mention id="M19" len="14" reason="general_term" section="S1" start="5061" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder nervous system" meddra_llt_id="10013242" meddra_pt="Nervous system disorder" meddra_pt_id="10029202" />
      <Normalization meddra_pt="Neurotoxicity" meddra_pt_id="10029350" />
      <Normalization meddra_pt="Neurological symptom" meddra_pt_id="10060860" />
    </Mention>
    <Mention id="M183" len="14" reason="from_drug_use" section="S1" start="5078" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Encephalopathy" meddra_llt_id="10014625" meddra_pt="Encephalopathy" meddra_pt_id="10014625" />
    </Mention>
    <Mention id="M184" len="10" reason="from_drug_use" section="S1" start="5094" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Convulsion" meddra_llt_id="10010904" meddra_pt="Seizure" meddra_pt_id="10039906" />
    </Mention>
    <Mention id="M185" len="9" reason="from_drug_use" section="S1" start="5106" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dizziness" meddra_llt_id="10013573" meddra_pt="Dizziness" meddra_pt_id="10013573" />
    </Mention>
    <Mention id="M186" len="13" reason="from_drug_use" section="S1" start="5117" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Neurotoxicity" meddra_llt_id="10029350" meddra_pt="Neurotoxicity" meddra_pt_id="10029350" />
      <Normalization meddra_pt="Nervous system disorder" meddra_pt_id="10029202" />
      <Normalization meddra_pt="Neurological symptom" meddra_pt_id="10060860" />
    </Mention>
    <Mention id="M187" len="49" reason="from_drug_use" section="S1" start="5167" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Reversible posterior leukoencephalopathy syndrome" meddra_llt_id="10063761" meddra_pt="Posterior reversible encephalopathy syndrome" meddra_pt_id="10071066" />
    </Mention>
    <Mention id="M200" len="10" reason="from_drug_use" section="S1" start="5218" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myelopathy" meddra_llt_id="10028570" meddra_pt="Myelopathy" meddra_pt_id="10028570" />
    </Mention>
    <Mention id="M188" len="21" reason="from_drug_use" section="S1" start="5230" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Neuropathy peripheral" meddra_llt_id="10029331" meddra_pt="Neuropathy peripheral" meddra_pt_id="10029331" />
    </Mention>
    <Mention id="M189" len="14" reason="from_drug_use" section="S1" start="5253" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Polyneuropathy" meddra_llt_id="10036105" meddra_pt="Polyneuropathy" meddra_pt_id="10036105" />
    </Mention>
    <Mention id="M190" len="9" reason="from_drug_use" section="S1" start="5269" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Neuralgia" meddra_llt_id="10029223" meddra_pt="Neuralgia" meddra_pt_id="10029223" />
    </Mention>
    <Mention id="M191" len="11" reason="from_drug_use" section="S1" start="5280" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dysesthesia" meddra_llt_id="10062872" meddra_pt="Dysaesthesia" meddra_pt_id="10013886" />
    </Mention>
    <Mention id="M192" len="12" reason="from_drug_use" section="S1" start="5293" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hypoesthesia" meddra_llt_id="10020976" meddra_pt="Hypoaesthesia" meddra_pt_id="10020937" />
    </Mention>
    <Mention id="M193" len="11" reason="from_drug_use" section="S1" start="5307" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Paresthesia" meddra_llt_id="10033987" meddra_pt="Paraesthesia" meddra_pt_id="10033775" />
    </Mention>
    <Mention id="M194" len="6" reason="from_drug_use" section="S1" start="5320" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Tremor" meddra_llt_id="10044565" meddra_pt="Tremor" meddra_pt_id="10044565" />
    </Mention>
    <Mention id="M195" len="9" reason="from_drug_use" section="S1" start="5328" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dysgeusia" meddra_llt_id="10013911" meddra_pt="Dysgeusia" meddra_pt_id="10013911" />
    </Mention>
    <Mention id="M196" len="10" reason="from_drug_use" section="S1" start="5339" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hypogeusia" meddra_llt_id="10020989" meddra_pt="Hypogeusia" meddra_pt_id="10020989" />
    </Mention>
    <Mention id="M197" len="8" reason="from_drug_use" section="S1" start="5351" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Parosmia" meddra_llt_id="10034018" meddra_pt="Parosmia" meddra_pt_id="10034018" />
    </Mention>
    <Mention id="M20" len="9" reason="general_term" section="S1" start="5365" type="NonOSE_AE">
      <Normalization meddra_llt="Pregnancy" meddra_llt_id="10036556" meddra_pt="Pregnancy" meddra_pt_id="10036556" />
    </Mention>
    <Mention id="M198" len="15" reason="from_drug_use" section="S1" start="5377" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Labor premature" meddra_llt_id="10023545" meddra_pt="Premature labour" meddra_pt_id="10036600" />
    </Mention>
    <Mention id="M21" len="11" reason="general_term" section="S1" start="5398" type="NonOSE_AE">
      <Normalization meddra_llt="Psychiatric disorder NOS" meddra_llt_id="10037174" meddra_pt="Mental disorder" meddra_pt_id="10061284" />
      <Normalization meddra_pt="Psychiatric symptom" meddra_pt_id="10061472" />
    </Mention>
    <Mention id="M199" len="17" reason="from_drug_use" section="S1" start="5412" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Confusional state" meddra_llt_id="10010305" meddra_pt="Confusional state" meddra_pt_id="10010305" />
    </Mention>
    <Mention id="M22" len="17" reason="general_term" section="S1" start="5435" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder urinary tract" meddra_llt_id="10013278" meddra_pt="Urinary tract disorder" meddra_pt_id="10046566" />
    </Mention>
    <Mention id="M201" len="13" reason="from_drug_use" section="S1" start="5455" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Renal failure" meddra_llt_id="10038435" meddra_pt="Renal failure" meddra_pt_id="10038435" />
    </Mention>
    <Mention id="M202" len="22" reason="from_drug_use" section="S1" start="5470" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Renal tubular disorder" meddra_llt_id="10038537" meddra_pt="Renal tubular disorder" meddra_pt_id="10038537" />
    </Mention>
    <Mention id="M203" len="16" reason="from_drug_use" section="S1" start="5494" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Renal impairment" meddra_llt_id="10062237" meddra_pt="Renal impairment" meddra_pt_id="10062237" />
    </Mention>
    <Mention id="M204" len="17" reason="from_drug_use" section="S1" start="5512" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Nephropathy toxic" meddra_llt_id="10029155" meddra_pt="Nephropathy toxic" meddra_pt_id="10029155" />
    </Mention>
    <Mention id="M205" len="20" reason="from_drug_use" section="S1" start="5531" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hemorrhagic cystitis" meddra_llt_id="10019598" meddra_pt="Cystitis haemorrhagic" meddra_pt_id="10011793" />
    </Mention>
    <Mention id="M206" len="16" reason="from_drug_use" section="S1" start="5553" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Bladder necrosis" meddra_llt_id="10051258" meddra_pt="Bladder necrosis" meddra_pt_id="10051258" />
    </Mention>
    <Mention id="M207" len="19" reason="from_drug_use" section="S1" start="5571" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cystitis ulcerative" meddra_llt_id="10011801" meddra_pt="Cystitis ulcerative" meddra_pt_id="10011801" />
    </Mention>
    <Mention id="M208" len="19" reason="from_drug_use" section="S1" start="5592" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Bladder neck contracture" meddra_llt_id="10069209" meddra_pt="Bladder neck obstruction" meddra_pt_id="10005053" />
    </Mention>
    <Mention id="M209" len="9" reason="from_drug_use" section="S1" start="5613" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hematuria" meddra_llt_id="10019450" meddra_pt="Haematuria" meddra_pt_id="10018867" />
    </Mention>
    <Mention id="M210" len="30" reason="from_drug_use" section="S1" start="5624" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Nephrogenic diabetes insipidus" meddra_llt_id="10029147" meddra_pt="Nephrogenic diabetes insipidus" meddra_pt_id="10029147" />
    </Mention>
    <Mention id="M211" len="41" reason="from_drug_use" section="S1" start="5656" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Biopsy bladder abnormal" meddra_llt_id="10004731" meddra_pt="Biopsy bladder abnormal" meddra_pt_id="10004731" />
    </Mention>
    <Mention id="M23" len="19" reason="general_term" section="S1" start="5703" type="NonOSE_AE">
      <Normalization meddra_llt="Reproductive tract disorder" meddra_llt_id="10061483" meddra_pt="Reproductive tract disorder" meddra_pt_id="10061483" />
      <Normalization meddra_pt="Reproductive toxicity" meddra_pt_id="10074268" />
    </Mention>
    <Mention id="M212" len="11" reason="from_drug_use" section="S1" start="5725" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infertility" meddra_llt_id="10021926" meddra_pt="Infertility" meddra_pt_id="10021926" />
    </Mention>
    <Mention id="M213" len="15" reason="from_drug_use" section="S1" start="5738" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Ovarian failure" meddra_llt_id="10033165" meddra_pt="Ovarian failure" meddra_pt_id="10033165" />
    </Mention>
    <Mention id="M214" len="16" reason="from_drug_use" section="S1" start="5755" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Disorder ovarian" meddra_llt_id="10013249" meddra_pt="Ovarian disorder" meddra_pt_id="10033139" />
    </Mention>
    <Mention id="M215" len="10" reason="from_drug_use" section="S1" start="5773" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Amenorrhea" meddra_llt_id="10001927" meddra_pt="Amenorrhoea" meddra_pt_id="10001928" />
    </Mention>
    <Mention id="M216" len="14" reason="from_drug_use" section="S1" start="5785" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Oligomenorrhea" meddra_llt_id="10030294" meddra_pt="Oligomenorrhoea" meddra_pt_id="10030295" />
    </Mention>
    <Mention id="M217" len="18" reason="from_drug_use" section="S1" start="5801" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Atrophy testicular" meddra_llt_id="10003720" meddra_pt="Testicular atrophy" meddra_pt_id="10043298" />
    </Mention>
    <Mention id="M218" len="11" reason="from_drug_use" section="S1" start="5821" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Azoospermia" meddra_llt_id="10003883" meddra_pt="Azoospermia" meddra_pt_id="10003883" />
    </Mention>
    <Mention id="M219" len="12" reason="from_drug_use" section="S1" start="5834" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Oligospermia" meddra_llt_id="10030300" meddra_pt="Oligospermia" meddra_pt_id="10030300" />
    </Mention>
    <Mention id="M24" len="11" reason="general_term" section="S1" start="5852" type="NonOSE_AE">
      <Normalization meddra_llt="Respiratory disorder" meddra_llt_id="10038683" meddra_pt="Respiratory disorder" meddra_pt_id="10038683" />
    </Mention>
    <Mention id="M220" len="32" reason="from_drug_use" section="S1" start="5866" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pulmonary veno-occlusive disease" meddra_llt_id="10037458" meddra_pt="Pulmonary veno-occlusive disease" meddra_pt_id="10037458" />
    </Mention>
    <Mention id="M221" len="35" reason="from_drug_use" section="S1" start="5900" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Acute respiratory distress syndrome" meddra_llt_id="10001052" meddra_pt="Acute respiratory distress syndrome" meddra_pt_id="10001052" />
    </Mention>
    <Mention id="M222" len="25" reason="from_drug_use" section="S1" start="5937" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Interstitial lung disease" meddra_llt_id="10022611" meddra_pt="Interstitial lung disease" meddra_pt_id="10022611" />
    </Mention>
    <Mention id="M30" len="19" reason="manifestation_or_complication" section="S1" start="5980" type="NonOSE_AE">
      <Normalization meddra_llt="Failure respiratory" meddra_llt_id="10016162" meddra_pt="Respiratory failure" meddra_pt_id="10038695" />
    </Mention>
    <Mention id="M31" len="5" reason="general_term" section="S1" start="6011" type="NonOSE_AE">
      <Normalization meddra_llt="Death" meddra_llt_id="10011906" meddra_pt="Death" meddra_pt_id="10011906" />
    </Mention>
    <Mention id="M223" len="26" reason="from_drug_use" section="S1" start="6028" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Obliterative bronchiolitis" meddra_llt_id="10029888" meddra_pt="Obliterative bronchiolitis" meddra_pt_id="10029888" />
    </Mention>
    <Mention id="M224" len="20" reason="from_drug_use" section="S1" start="6056" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Organizing pneumonia" meddra_llt_id="10067471" meddra_pt="Organising pneumonia" meddra_pt_id="10067472" />
    </Mention>
    <Mention id="M225" len="19" reason="from_drug_use" section="S1" start="6078" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Alveolitis allergic" meddra_llt_id="10001890" meddra_pt="Alveolitis allergic" meddra_pt_id="10001890" />
    </Mention>
    <Mention id="M226" len="11" reason="from_drug_use" section="S1" start="6099" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pneumonitis" meddra_llt_id="10035742" meddra_pt="Pneumonitis" meddra_pt_id="10035742" />
    </Mention>
    <Mention id="M227" len="20" reason="from_drug_use" section="S1" start="6112" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pulmonary hemorrhage" meddra_llt_id="10037397" meddra_pt="Pulmonary haemorrhage" meddra_pt_id="10037394" />
    </Mention>
    <Mention id="M228" len="20" reason="from_drug_use" section="S1" start="6134" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Distress respiratory" meddra_llt_id="10013492" meddra_pt="Respiratory distress" meddra_pt_id="10038687" />
    </Mention>
    <Mention id="M229" len="22" reason="from_drug_use" section="S1" start="6156" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pulmonary hypertension" meddra_llt_id="10037400" meddra_pt="Pulmonary hypertension" meddra_pt_id="10037400" />
    </Mention>
    <Mention id="M230" len="15" reason="from_drug_use" section="S1" start="6180" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pulmonary edema" meddra_llt_id="10037375" meddra_pt="Pulmonary oedema" meddra_pt_id="10037423" />
    </Mention>
    <Mention id="M231" len="16" reason="from_drug_use" section="S1" start="6197" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Effusion pleural" meddra_llt_id="10014313" meddra_pt="Pleural effusion" meddra_pt_id="10035598" />
    </Mention>
    <Mention id="M232" len="12" reason="from_drug_use" section="S1" start="6215" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Bronchospasm" meddra_llt_id="10006482" meddra_pt="Bronchospasm" meddra_pt_id="10006482" />
    </Mention>
    <Mention id="M233" len="7" reason="from_drug_use" section="S1" start="6229" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dyspnea" meddra_llt_id="10013963" meddra_pt="Dyspnoea" meddra_pt_id="10013968" />
    </Mention>
    <Mention id="M234" len="7" reason="from_drug_use" section="S1" start="6238" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hypoxia" meddra_llt_id="10021143" meddra_pt="Hypoxia" meddra_pt_id="10021143" />
    </Mention>
    <Mention id="M235" len="5" reason="from_drug_use" section="S1" start="6247" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cough" meddra_llt_id="10011224" meddra_pt="Cough" meddra_pt_id="10011224" />
    </Mention>
    <Mention id="M236" len="16" reason="from_drug_use" section="S1" start="6254" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Congestion nasal" meddra_llt_id="10010676" meddra_pt="Nasal congestion" meddra_pt_id="10028735" />
    </Mention>
    <Mention id="M237" len="16" reason="from_drug_use" section="S1" start="6272" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Nasal discomfort" meddra_llt_id="10052437" meddra_pt="Nasal discomfort" meddra_pt_id="10052437" />
    </Mention>
    <Mention id="M238" len="18" reason="from_drug_use" section="S1" start="6290" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Oropharyngeal pain" meddra_llt_id="10068319" meddra_pt="Oropharyngeal pain" meddra_pt_id="10068319" />
    </Mention>
    <Mention id="M239" len="10" reason="from_drug_use" section="S1" start="6310" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Rhinorrhea" meddra_llt_id="10039100" meddra_pt="Rhinorrhoea" meddra_pt_id="10039101" />
    </Mention>
    <Mention id="M25" len="28" reason="general_term" section="S1" start="6326" type="NonOSE_AE">
      <Normalization meddra_llt="Skin disorder" meddra_llt_id="10040831" meddra_pt="Skin disorder" meddra_pt_id="10040831" />
    </Mention>
    <Mention id="M240" len="26" reason="from_drug_use" section="S1" start="6357" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Toxic epidermal necrolysis" meddra_llt_id="10044223" meddra_pt="Toxic epidermal necrolysis" meddra_pt_id="10044223" />
    </Mention>
    <Mention id="M241" len="24" reason="from_drug_use" section="S1" start="6385" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Syndrome Stevens-Johnson" meddra_llt_id="10042849" meddra_pt="Stevens-Johnson syndrome" meddra_pt_id="10042033" />
    </Mention>
    <Mention id="M242" len="19" reason="from_drug_use" section="S1" start="6411" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Erythema multiforme" meddra_llt_id="10015218" meddra_pt="Erythema multiforme" meddra_pt_id="10015218" />
    </Mention>
    <Mention id="M243" len="42" reason="from_drug_use" section="S1" start="6432" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Palmar-plantar erythrodysesthesia syndrome" meddra_llt_id="10054524" meddra_pt="Palmar-plantar erythrodysaesthesia syndrome" meddra_pt_id="10033553" />
    </Mention>
    <Mention id="M244" len="27" reason="from_drug_use" section="S1" start="6476" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Radiation recall syndrome" meddra_llt_id="10037768" meddra_pt="Recall phenomenon" meddra_pt_id="10060856" />
    </Mention>
    <Mention id="M245" len="19" reason="from_drug_use" section="S1" start="6505" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Toxic skin eruption" meddra_llt_id="10057970" meddra_pt="Toxic skin eruption" meddra_pt_id="10057970" />
    </Mention>
    <Mention id="M246" len="9" reason="from_drug_use" section="S1" start="6526" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Urticaria" meddra_llt_id="10046735" meddra_pt="Urticaria" meddra_pt_id="10046735" />
    </Mention>
    <Mention id="M247" len="10" reason="from_drug_use" section="S1" start="6537" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dermatitis" meddra_llt_id="10012431" meddra_pt="Dermatitis" meddra_pt_id="10012431" />
    </Mention>
    <Mention id="M248" len="7" reason="from_drug_use" section="S1" start="6549" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Blister" meddra_llt_id="10005191" meddra_pt="Blister" meddra_pt_id="10005191" />
    </Mention>
    <Mention id="M249" len="8" reason="from_drug_use" section="S1" start="6558" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pruritus" meddra_llt_id="10037087" meddra_pt="Pruritus" meddra_pt_id="10037087" />
    </Mention>
    <Mention id="M250" len="8" reason="from_drug_use" section="S1" start="6568" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Erythema" meddra_llt_id="10015150" meddra_pt="Erythema" meddra_pt_id="10015150" />
    </Mention>
    <Mention id="M251" len="13" reason="from_drug_use" section="S1" start="6578" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Nail disorder" meddra_llt_id="10028694" meddra_pt="Nail disorder" meddra_pt_id="10028694" />
    </Mention>
    <Mention id="M252" len="15" reason="from_drug_use" section="S1" start="6593" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Facial swelling" meddra_llt_id="10016065" meddra_pt="Swelling face" meddra_pt_id="10042682" />
    </Mention>
    <Mention id="M253" len="13" reason="from_drug_use" section="S1" start="6610" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hyperhidrosis" meddra_llt_id="10020642" meddra_pt="Hyperhidrosis" meddra_pt_id="10020642" />
    </Mention>
    <Mention id="M32" len="20" reason="general_term" section="S1" start="6629" type="NonOSE_AE">
      <Normalization meddra_llt="Tumor lysis syndrome" meddra_llt_id="10045152" meddra_pt="Tumour lysis syndrome" meddra_pt_id="10045170" />
    </Mention>
    <Mention id="M254" len="20" reason="from_drug_use" section="S1" start="6712" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Tumor lysis syndrome" meddra_llt_id="10045152" meddra_pt="Tumour lysis syndrome" meddra_pt_id="10045170" />
    </Mention>
    <Mention id="M255" len="13" reason="from_drug_use" section="S1" start="6737" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hyperuricemia" meddra_llt_id="10020907" meddra_pt="Hyperuricaemia" meddra_pt_id="10020903" />
    </Mention>
    <Mention id="M1" len="6" reason="preexisting_condition_or_risk_factor" section="S1" start="6784" type="Not_AE_Candidate">
      <Normalization meddra_llt="Neoplasm" meddra_llt_id="10028980" meddra_pt="Neoplasm" meddra_pt_id="10028980" />
    </Mention>
    <Mention id="M26" len="8" reason="general_term" section="S1" start="6796" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder vascular" meddra_llt_id="10013282" meddra_pt="Angiopathy" meddra_pt_id="10059245" />
    </Mention>
    <Mention id="M256" len="18" reason="from_drug_use" section="S1" start="6807" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pulmonary embolism" meddra_llt_id="10037377" meddra_pt="Pulmonary embolism" meddra_pt_id="10037377" />
    </Mention>
    <Mention id="M257" len="17" reason="from_drug_use" section="S1" start="6827" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Thrombosis venous" meddra_llt_id="10043640" meddra_pt="Venous thrombosis" meddra_pt_id="10047249" />
    </Mention>
    <Mention id="M258" len="10" reason="from_drug_use" section="S1" start="6846" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Vasculitis" meddra_llt_id="10047115" meddra_pt="Vasculitis" meddra_pt_id="10047115" />
    </Mention>
    <Mention id="M259" len="19" reason="from_drug_use" section="S1" start="6858" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Ischemia peripheral" meddra_llt_id="10023034" meddra_pt="Peripheral ischaemia" meddra_pt_id="10034576" />
    </Mention>
    <Mention id="M260" len="12" reason="from_drug_use" section="S1" start="6879" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hypertension" meddra_llt_id="10020772" meddra_pt="Hypertension" meddra_pt_id="10020772" />
    </Mention>
    <Mention id="M261" len="11" reason="from_drug_use" section="S1" start="6893" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hypotension" meddra_llt_id="10021097" meddra_pt="Hypotension" meddra_pt_id="10021097" />
    </Mention>
    <Mention id="M262" len="8" reason="from_drug_use" section="S1" start="6906" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Flushing" meddra_llt_id="10016825" meddra_pt="Flushing" meddra_pt_id="10016825" />
    </Mention>
    <Mention id="M263" len="9" reason="from_drug_use" section="S1" start="6916" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hot flush" meddra_llt_id="10060800" meddra_pt="Hot flush" meddra_pt_id="10060800" />
    </Mention>
    <Mention id="M330" len="16" reason="from_drug_use" section="S2" start="1309" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myelosuppression" meddra_llt_id="10028584" meddra_pt="Bone marrow failure" meddra_pt_id="10065553" />
    </Mention>
    <Mention id="M331" len="10" reason="from_drug_use" section="S2" start="1327" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Leukopenia" meddra_llt_id="10024384" meddra_pt="Leukopenia" meddra_pt_id="10024384" />
    </Mention>
    <Mention id="M332" len="11" reason="from_drug_use" section="S2" start="1339" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Neutropenia" meddra_llt_id="10029354" meddra_pt="Neutropenia" meddra_pt_id="10029354" />
    </Mention>
    <Mention id="M333" len="16" reason="from_drug_use" section="S2" start="1352" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Thrombocytopenia" meddra_llt_id="10043554" meddra_pt="Thrombocytopenia" meddra_pt_id="10043554" />
    </Mention>
    <Mention id="M334" len="6" reason="from_drug_use" section="S2" start="1373" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Anemia" meddra_llt_id="10002272" meddra_pt="Anaemia" meddra_pt_id="10002034" />
    </Mention>
    <Mention id="M335" len="19" reason="from_drug_use" section="S2" start="1382" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Bone marrow failure" meddra_llt_id="10065553" meddra_pt="Bone marrow failure" meddra_pt_id="10065553" />
    </Mention>
    <Mention id="M336" len="17" reason="from_drug_use" section="S2" start="1414" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Immunosuppression" meddra_llt_id="10062016" meddra_pt="Immunosuppression" meddra_pt_id="10062016" />
    </Mention>
    <Mention id="M283" len="5" reason="general_term" section="S2" start="1472" type="NonOSE_AE">
      <Normalization meddra_llt="Death" meddra_llt_id="10011906" meddra_pt="Death" meddra_pt_id="10011906" />
    </Mention>
    <Mention id="M282" len="10" reason="manifestation_or_complication" section="S2" start="1478" type="NonOSE_AE">
      <Normalization meddra_llt="Infection" meddra_llt_id="10021789" meddra_pt="Infection" meddra_pt_id="10021789" />
    </Mention>
    <Mention id="M284" len="6" reason="manifestation_or_complication" section="S2" start="1500" type="NonOSE_AE">
      <Normalization meddra_llt="Sepsis" meddra_llt_id="10040047" meddra_pt="Sepsis" meddra_pt_id="10040047" />
    </Mention>
    <Mention id="M285" len="12" reason="manifestation_or_complication" section="S2" start="1511" type="NonOSE_AE">
      <Normalization meddra_llt="Septic shock" meddra_llt_id="10040070" meddra_pt="Septic shock" meddra_pt_id="10040070" />
    </Mention>
    <Mention id="M338" len="36" reason="from_drug_use" section="S2" start="1525" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infection reactivation" meddra_llt_id="10070891" meddra_pt="Infection reactivation" meddra_pt_id="10070891" />
      <Normalization meddra_pt="Viral infection" meddra_pt_id="10047461" />
    </Mention>
    <Mention id="M286" len="11" reason="AE_only_as_instruction" section="S2" start="1661" type="NonOSE_AE">
      <Normalization meddra_llt="Neutropenia" meddra_llt_id="10029354" meddra_pt="Neutropenia" meddra_pt_id="10029354" />
    </Mention>
    <Mention id="M287" len="17" reason="AE_only_as_instruction" section="S2" start="1729" type="NonOSE_AE">
      <Normalization meddra_llt="Neutropenic fever" meddra_llt_id="10051312" meddra_pt="Febrile neutropenia" meddra_pt_id="10016288" />
    </Mention>
    <Mention id="M272" len="25" reason="preexisting_condition_or_risk_factor" section="S2" start="2026" type="Not_AE_Candidate">
      <Normalization meddra_llt="Neutrophil count decreased" meddra_llt_id="10029366" meddra_pt="Neutrophil count decreased" meddra_pt_id="10029366" />
    </Mention>
    <Mention id="M273" len="24" reason="preexisting_condition_or_risk_factor" section="S2" start="2057" type="Not_AE_Candidate">
      <Normalization meddra_llt="Platelet count decreased" meddra_llt_id="10035528" meddra_pt="Platelet count decreased" meddra_pt_id="10035528" />
    </Mention>
    <Mention id="M288" len="9" reason="AE_only_as_instruction" section="S2" start="2227" type="NonOSE_AE">
      <Normalization meddra_llt="Infection" meddra_llt_id="10021789" meddra_pt="Infection" meddra_pt_id="10021789" />
    </Mention>
    <Mention id="M289" len="11" reason="AE_only_as_instruction" section="S2" start="2287" type="NonOSE_AE">
      <Normalization meddra_llt="Neutropenia" meddra_llt_id="10029354" meddra_pt="Neutropenia" meddra_pt_id="10029354" />
    </Mention>
    <Mention id="M290" len="11" reason="AE_only_as_instruction" section="S2" start="2472" type="NonOSE_AE">
      <Normalization meddra_llt="Neutropenia" meddra_llt_id="10029354" meddra_pt="Neutropenia" meddra_pt_id="10029354" />
    </Mention>
    <Mention id="M291" len="28" reason="AE_only_as_instruction" section="S2" start="2517" type="NonOSE_AE">
      <Normalization meddra_llt="Leukocyte count decreased" meddra_llt_id="10048552" meddra_pt="White blood cell count decreased" meddra_pt_id="10047942" />
    </Mention>
    <Mention id="M292" len="12,17" reason="AE_only_as_instruction" section="S2" start="2517,2550" type="NonOSE_AE">
      <Normalization meddra_llt="Thrombocyte count decreased" meddra_llt_id="10043546" meddra_pt="Platelet count decreased" meddra_pt_id="10035528" />
    </Mention>
    <Mention id="M337" len="19" reason="from_drug_use" section="S2" start="2703" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Bone marrow failure" meddra_llt_id="10065553" meddra_pt="Bone marrow failure" meddra_pt_id="10065553" />
    </Mention>
    <Mention id="M293" len="16" reason="AE_from_drug_interaction" section="S2" start="2749" type="NonOSE_AE">
      <Normalization meddra_llt="Myelosuppression" meddra_llt_id="10028584" meddra_pt="Bone marrow failure" meddra_pt_id="10065553" />
    </Mention>
    <Mention id="M339" len="20" reason="from_drug_use" section="S2" start="2936" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hemorrhagic cystitis" meddra_llt_id="10019598" meddra_pt="Cystitis haemorrhagic" meddra_pt_id="10011793" />
    </Mention>
    <Mention id="M340" len="8" reason="from_drug_use" section="S2" start="2958" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pyelitis" meddra_llt_id="10037584" meddra_pt="Pyelitis" meddra_pt_id="10037584" />
    </Mention>
    <Mention id="M341" len="10" reason="from_drug_use" section="S2" start="2968" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Ureteritis" meddra_llt_id="10051250" meddra_pt="Ureteritis" meddra_pt_id="10051250" />
    </Mention>
    <Mention id="M342" len="9" reason="from_drug_use" section="S2" start="2984" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hematuria" meddra_llt_id="10019450" meddra_pt="Haematuria" meddra_pt_id="10018867" />
    </Mention>
    <Mention id="M294" len="20" reason="AE_only_as_instruction" section="S2" start="3133" type="NonOSE_AE">
      <Normalization meddra_llt="Hemorrhagic cystitis" meddra_llt_id="10019598" meddra_pt="Cystitis haemorrhagic" meddra_pt_id="10011793" />
    </Mention>
    <Mention id="M295" len="20" reason="AE_only_as_instruction" section="S2" start="3210" type="NonOSE_AE">
      <Normalization meddra_llt="Hemorrhagic cystitis" meddra_llt_id="10019598" meddra_pt="Cystitis haemorrhagic" meddra_pt_id="10011793" />
    </Mention>
    <Mention id="M324" len="11" reason="AE_only_as_instruction" section="S2" start="3232" type="NonOSE_AE">
      <Normalization meddra_llt="Urinary bladder toxicity" meddra_llt_id="10072996" meddra_pt="Urinary bladder toxicity" meddra_pt_id="10072996" />
    </Mention>
    <Mention id="M325" len="18" reason="manifestation_or_complication" section="S2" start="3245" type="NonOSE_AE">
      <Normalization meddra_llt="Cystitis ulcerative" meddra_llt_id="10011801" meddra_pt="Cystitis ulcerative" meddra_pt_id="10011801" />
    </Mention>
    <Mention id="M326" len="7,8" reason="manifestation_or_complication" section="S2" start="3245,3265" type="NonOSE_AE">
      <Normalization meddra_llt="Bladder necrosis" meddra_llt_id="10051258" meddra_pt="Bladder necrosis" meddra_pt_id="10051258" />
    </Mention>
    <Mention id="M327" len="7,8" reason="manifestation_or_complication" section="S2" start="3245,3275" type="NonOSE_AE">
      <Normalization meddra_llt="Bladder fibrosis" meddra_llt_id="10005042" meddra_pt="Bladder fibrosis" meddra_pt_id="10005042" />
    </Mention>
    <Mention id="M328" len="7,11" reason="manifestation_or_complication" section="S2" start="3245,3285" type="NonOSE_AE">
      <Normalization meddra_llt="Bladder neck contracture" meddra_llt_id="10069209" meddra_pt="Bladder neck obstruction" meddra_pt_id="10005053" />
    </Mention>
    <Mention id="M329" len="7,16" reason="manifestation_or_complication" section="S2" start="3245,3301" type="NonOSE_AE">
      <Normalization meddra_llt="Bladder cancer" meddra_llt_id="10005003" meddra_pt="Bladder cancer" meddra_pt_id="10005003" />
    </Mention>
    <Mention id="M296" len="11" reason="AE_only_as_instruction" section="S2" start="3389" type="NonOSE_AE">
      <Normalization meddra_llt="Urinary bladder toxicity" meddra_llt_id="10072996" meddra_pt="Urinary bladder toxicity" meddra_pt_id="10072996" />
    </Mention>
    <Mention id="M297" len="5" reason="general_term" section="S2" start="3408" type="NonOSE_AE">
      <Normalization meddra_llt="Death" meddra_llt_id="10011906" meddra_pt="Death" meddra_pt_id="10011906" />
    </Mention>
    <Mention id="M343" len="11" reason="from_drug_use" section="S2" start="3415" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Urinary bladder toxicity" meddra_llt_id="10072996" meddra_pt="Urinary bladder toxicity" meddra_pt_id="10072996" />
    </Mention>
    <Mention id="M274" len="26" reason="contraindication" section="S2" start="3543" type="Not_AE_Candidate">
      <Normalization meddra_llt="Urinary tract obstruction" meddra_llt_id="10061574" meddra_pt="Urinary tract obstruction" meddra_pt_id="10061574" />
    </Mention>
    <Mention id="M298" len="11" reason="AE_only_as_instruction" section="S2" start="3699" type="NonOSE_AE">
      <Normalization meddra_llt="Urinary bladder toxicity" meddra_llt_id="10072996" meddra_pt="Urinary bladder toxicity" meddra_pt_id="10072996" />
    </Mention>
    <Mention id="M299" len="14" reason="AE_only_as_instruction" section="S2" start="3718" type="NonOSE_AE">
      <Normalization meddra_llt="Nephrotoxicity" meddra_llt_id="10067571" meddra_pt="Nephropathy toxic" meddra_pt_id="10029155" />
    </Mention>
    <Mention id="M275" len="24" reason="preexisting_condition_or_risk_factor" section="S2" start="3815" type="Not_AE_Candidate">
      <Normalization meddra_llt="Infection urinary tract" meddra_llt_id="10021872" meddra_pt="Urinary tract infection" meddra_pt_id="10046571" />
    </Mention>
    <Mention id="M300" len="8" reason="AE_only_as_instruction" section="S2" start="3874" type="NonOSE_AE">
      <Normalization meddra_llt="Diuresis" meddra_llt_id="10013523" meddra_pt="Polyuria" meddra_pt_id="10036142" />
    </Mention>
    <Mention id="M301" len="16" reason="AE_only_as_instruction" section="S2" start="3896" type="NonOSE_AE">
      <Normalization meddra_llt="Pollakiuria" meddra_llt_id="10036018" meddra_pt="Pollakiuria" meddra_pt_id="10036018" />
    </Mention>
    <Mention id="M302" len="16" reason="AE_only_as_instruction" section="S2" start="3954" type="NonOSE_AE">
      <Normalization meddra_llt="Urinary bladder toxicity" meddra_llt_id="10072996" meddra_pt="Urinary bladder toxicity" meddra_pt_id="10072996" />
    </Mention>
    <Mention id="M303" len="16" reason="AE_only_as_instruction" section="S2" start="4010" type="NonOSE_AE">
      <Normalization meddra_llt="Urinary bladder toxicity" meddra_llt_id="10072996" meddra_pt="Urinary bladder toxicity" meddra_pt_id="10072996" />
    </Mention>
    <Mention id="M344" len="11" reason="from_drug_use" section="S2" start="4055" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myocarditis" meddra_llt_id="10028606" meddra_pt="Myocarditis" meddra_pt_id="10028606" />
    </Mention>
    <Mention id="M345" len="15" reason="from_drug_use" section="S2" start="4068" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myopericarditis" meddra_llt_id="10028650" meddra_pt="Myocarditis" meddra_pt_id="10028606" />
    </Mention>
    <Mention id="M346" len="20" reason="from_drug_use" section="S2" start="4085" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Effusion pericardial" meddra_llt_id="10014311" meddra_pt="Pericardial effusion" meddra_pt_id="10034474" />
    </Mention>
    <Mention id="M347" len="17" reason="from_drug_use" section="S2" start="4116" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cardiac tamponade" meddra_llt_id="10007610" meddra_pt="Cardiac tamponade" meddra_pt_id="10007610" />
    </Mention>
    <Mention id="M348" len="24" reason="from_drug_use" section="S2" start="4139" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Congestive heart failure" meddra_llt_id="10010684" meddra_pt="Cardiac failure congestive" meddra_pt_id="10007559" />
    </Mention>
    <Mention id="M304" len="5" reason="general_term" section="S2" start="4178" type="NonOSE_AE">
      <Normalization meddra_llt="Death" meddra_llt_id="10011906" meddra_pt="Death" meddra_pt_id="10011906" />
    </Mention>
    <Mention id="M349" len="28" reason="from_drug_use" section="S2" start="4236" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Arrhythmia supraventricular" meddra_llt_id="10003130" meddra_pt="Arrhythmia supraventricular" meddra_pt_id="10003130" />
    </Mention>
    <Mention id="M350" len="6,7" reason="from_drug_use" section="S2" start="4276,4300" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Flutter atrial" meddra_llt_id="10016827" meddra_pt="Atrial flutter" meddra_pt_id="10003662" />
    </Mention>
    <Mention id="M351" len="19" reason="from_drug_use" section="S2" start="4276" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Atrial fibrillation" meddra_llt_id="10003658" meddra_pt="Atrial fibrillation" meddra_pt_id="10003658" />
    </Mention>
    <Mention id="M352" len="23" reason="from_drug_use" section="S2" start="4313" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Arrhythmia ventricular" meddra_llt_id="10003131" meddra_pt="Ventricular arrhythmia" meddra_pt_id="10047281" />
    </Mention>
    <Mention id="M353" len="15" reason="from_drug_use" section="S2" start="4355" type="OSE_Labeled_AE">
      <Normalization meddra_llt="QT increased" meddra_llt_id="10037700" meddra_pt="Electrocardiogram QT prolonged" meddra_pt_id="10014387" />
    </Mention>
    <Mention id="M354" len="27" reason="from_drug_use" section="S2" start="4387" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Ventricular tachyarrhythmia" meddra_llt_id="10065341" meddra_pt="Ventricular tachyarrhythmia" meddra_pt_id="10065341" />
    </Mention>
    <Mention id="M355" len="14" reason="from_drug_use" section="S2" start="4511" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cardiotoxicity" meddra_llt_id="10048610" meddra_pt="Cardiotoxicity" meddra_pt_id="10048610" />
    </Mention>
    <Mention id="M305" len="18" reason="AE_only_as_instruction" section="S2" start="4735" type="NonOSE_AE">
      <Normalization meddra_llt="Drug therapy" meddra_llt_id="10063370" meddra_pt="Drug therapy" meddra_pt_id="10063370" />
      <Normalization meddra_pt="Immunoglobulin therapy" meddra_pt_id="10069534" />
    </Mention>
    <Mention id="M306" len="14" reason="AE_only_as_instruction" section="S2" start="4823" type="NonOSE_AE">
      <Normalization meddra_llt="Cardiotoxicity" meddra_llt_id="10048610" meddra_pt="Cardiotoxicity" meddra_pt_id="10048610" />
    </Mention>
    <Mention id="M276" len="15" reason="preexisting_condition_or_risk_factor" section="S2" start="4872" type="Not_AE_Candidate">
      <Normalization meddra_llt="Cardiac disorder" meddra_llt_id="10061024" meddra_pt="Cardiac disorder" meddra_pt_id="10061024" />
    </Mention>
    <Mention id="M307" len="14" reason="AE_only_as_instruction" section="S2" start="4930" type="NonOSE_AE">
      <Normalization meddra_llt="Cardiotoxicity" meddra_llt_id="10048610" meddra_pt="Cardiotoxicity" meddra_pt_id="10048610" />
    </Mention>
    <Mention id="M277" len="15" reason="preexisting_condition_or_risk_factor" section="S2" start="4967" type="Not_AE_Candidate">
      <Normalization meddra_llt="Cardiac disorder" meddra_llt_id="10061024" meddra_pt="Cardiac disorder" meddra_pt_id="10061024" />
    </Mention>
    <Mention id="M356" len="11" reason="from_drug_use" section="S2" start="5015" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pneumonitis" meddra_llt_id="10035742" meddra_pt="Pneumonitis" meddra_pt_id="10035742" />
    </Mention>
    <Mention id="M357" len="18" reason="from_drug_use" section="S2" start="5028" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pulmonary fibrosis" meddra_llt_id="10037383" meddra_pt="Pulmonary fibrosis" meddra_pt_id="10037383" />
    </Mention>
    <Mention id="M358" len="32" reason="from_drug_use" section="S2" start="5048" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pulmonary veno-occlusive disease" meddra_llt_id="10037458" meddra_pt="Pulmonary veno-occlusive disease" meddra_pt_id="10037458" />
    </Mention>
    <Mention id="M359" len="18" reason="from_drug_use" section="S2" start="5100" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pulmonary toxicity" meddra_llt_id="10061924" meddra_pt="Pulmonary toxicity" meddra_pt_id="10061924" />
    </Mention>
    <Mention id="M308" len="19" reason="manifestation_or_complication" section="S2" start="5130" type="NonOSE_AE">
      <Normalization meddra_llt="Failure respiratory" meddra_llt_id="10016162" meddra_pt="Respiratory failure" meddra_pt_id="10038695" />
    </Mention>
    <Mention id="M309" len="11" reason="AE_only_as_instruction" section="S2" start="5234" type="NonOSE_AE">
      <Normalization meddra_llt="Pneumonitis" meddra_llt_id="10035742" meddra_pt="Pneumonitis" meddra_pt_id="10035742" />
    </Mention>
    <Mention id="M310" len="9" reason="general_term" section="S2" start="5342" type="NonOSE_AE">
      <Normalization meddra_llt="Death" meddra_llt_id="10011906" meddra_pt="Death" meddra_pt_id="10011906" />
    </Mention>
    <Mention id="M360" len="11" reason="from_drug_use" section="S2" start="5353" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pneumonitis" meddra_llt_id="10035742" meddra_pt="Pneumonitis" meddra_pt_id="10035742" />
    </Mention>
    <Mention id="M311" len="18" reason="AE_only_as_instruction" section="S2" start="5467" type="NonOSE_AE">
      <Normalization meddra_llt="Pulmonary toxicity" meddra_llt_id="10061924" meddra_pt="Pulmonary toxicity" meddra_pt_id="10061924" />
    </Mention>
    <Mention id="M361" len="9" reason="from_drug_use" section="S2" start="5542" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Genotoxicity" meddra_llt_id="10078948" meddra_pt="Genotoxicity" meddra_pt_id="10078948" />
    </Mention>
    <Mention id="M362" len="22" reason="from_drug_use" section="S2" start="5592" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Second primary malignancy" meddra_llt_id="10039801" meddra_pt="Second primary malignancy" meddra_pt_id="10039801" />
    </Mention>
    <Mention id="M363" len="20" reason="from_drug_use" section="S2" start="5616" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Malignant urinary tract neoplasm" meddra_llt_id="10061272" meddra_pt="Malignant urinary tract neoplasm" meddra_pt_id="10061272" />
    </Mention>
    <Mention id="M364" len="14" reason="from_drug_use" section="S2" start="5638" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myelodysplasia" meddra_llt_id="10028532" meddra_pt="Myelodysplastic syndrome" meddra_pt_id="10028533" />
    </Mention>
    <Mention id="M365" len="15" reason="from_drug_use" section="S2" start="5654" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Acute leukemia" meddra_llt_id="10000835" meddra_pt="Acute leukaemia" meddra_pt_id="10000830" />
    </Mention>
    <Mention id="M366" len="9" reason="from_drug_use" section="S2" start="5671" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Lymphoma" meddra_llt_id="10025310" meddra_pt="Lymphoma" meddra_pt_id="10025310" />
    </Mention>
    <Mention id="M367" len="14" reason="from_drug_use" section="S2" start="5682" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Thyroid cancer" meddra_llt_id="10066474" meddra_pt="Thyroid cancer" meddra_pt_id="10066474" />
    </Mention>
    <Mention id="M368" len="8" reason="from_drug_use" section="S2" start="5702" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Sarcoma" meddra_llt_id="10039491" meddra_pt="Sarcoma" meddra_pt_id="10039491" />
    </Mention>
    <Mention id="M312" len="14" reason="AE_only_as_instruction" section="S2" start="5808" type="NonOSE_AE">
      <Normalization meddra_llt="Bladder cancer" meddra_llt_id="10005003" meddra_pt="Bladder cancer" meddra_pt_id="10005003" />
    </Mention>
    <Mention id="M313" len="20" reason="AE_only_as_instruction" section="S2" start="5855" type="NonOSE_AE">
      <Normalization meddra_llt="Hemorrhagic cystitis" meddra_llt_id="10019598" meddra_pt="Cystitis haemorrhagic" meddra_pt_id="10011793" />
    </Mention>
    <Mention id="M369" len="33" reason="from_drug_use" section="S2" start="5918" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Veno-occlusive liver damage" meddra_llt_id="10047207" meddra_pt="Venoocclusive liver disease" meddra_pt_id="10047216" />
    </Mention>
    <Mention id="M314" len="5" reason="general_term" section="S2" start="5963" type="NonOSE_AE">
      <Normalization meddra_llt="Death" meddra_llt_id="10011906" meddra_pt="Death" meddra_pt_id="10011906" />
    </Mention>
    <Mention id="M278" len="27" reason="preexisting_condition_or_risk_factor" section="S2" start="6098" type="Not_AE_Candidate">
      <Normalization meddra_llt="Bone marrow transplant" meddra_llt_id="10061730" meddra_pt="Bone marrow transplant" meddra_pt_id="10061730" />
    </Mention>
    <Mention id="M370" len="3" reason="from_drug_use" section="S2" start="6274" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Veno-occlusive liver damage" meddra_llt_id="10047207" meddra_pt="Venoocclusive liver disease" meddra_pt_id="10047216" />
    </Mention>
    <Mention id="M315" len="17" reason="AE_only_as_instruction" section="S2" start="6363" type="NonOSE_AE">
      <Normalization meddra_llt="Immunosuppression" meddra_llt_id="10062016" meddra_pt="Immunosuppression" meddra_pt_id="10062016" />
    </Mention>
    <Mention id="M316" len="3" reason="AE_only_as_instruction" section="S2" start="6462" type="NonOSE_AE">
      <Normalization meddra_llt="Veno-occlusive liver damage" meddra_llt_id="10047207" meddra_pt="Venoocclusive liver disease" meddra_pt_id="10047216" />
    </Mention>
    <Mention id="M279" len="32" reason="preexisting_condition_or_risk_factor" section="S2" start="6486" type="Not_AE_Candidate">
      <Normalization meddra_llt="Hepatic function abnormal" meddra_llt_id="10019670" meddra_pt="Hepatic function abnormal" meddra_pt_id="10019670" />
    </Mention>
    <Mention id="M371" len="21" reason="from_drug_use" section="S2" start="6602" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Teratogenicity" meddra_llt_id="10043275" meddra_pt="Teratogenicity" meddra_pt_id="10043275" />
      <Normalization meddra_pt="Foetal damage" meddra_pt_id="10016852" />
      <Normalization meddra_pt="Maternal drugs affecting foetus" meddra_pt_id="10026923" />
    </Mention>
    <Mention id="M372" len="10" reason="from_drug_use" section="S2" start="6654" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fetal damage" meddra_llt_id="10054743" meddra_pt="Foetal damage" meddra_pt_id="10016852" />
      <Normalization meddra_pt="Teratogenicity" meddra_pt_id="10043275" />
      <Normalization meddra_pt="Maternal drugs affecting foetus" meddra_pt_id="10026923" />
    </Mention>
    <Mention id="M280" len="8" reason="preexisting_condition_or_risk_factor" section="S2" start="6688" type="Not_AE_Candidate">
      <Normalization meddra_llt="Pregnant" meddra_llt_id="10036586" meddra_pt="Pregnancy" meddra_pt_id="10036556" />
    </Mention>
    <Mention id="M281" len="9" reason="preexisting_condition_or_risk_factor" section="S2" start="6783" type="Not_AE_Candidate">
      <Normalization meddra_llt="Pregnancy" meddra_llt_id="10036556" meddra_pt="Pregnancy" meddra_pt_id="10036556" />
    </Mention>
    <Mention id="M373" len="13" reason="from_drug_use" section="S2" start="6803" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Birth defects" meddra_llt_id="10048305" meddra_pt="Congenital anomaly" meddra_pt_id="10010356" />
      <Normalization meddra_pt="Congenital anomaly in offspring" meddra_pt_id="10063726" />
    </Mention>
    <Mention id="M374" len="11" reason="from_drug_use" section="S2" start="6818" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Miscarriage" meddra_llt_id="10027649" meddra_pt="Abortion spontaneous" meddra_pt_id="10000234" />
    </Mention>
    <Mention id="M375" len="24" reason="from_drug_use" section="S2" start="6831" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fetal growth retardation" meddra_llt_id="10054746" meddra_pt="Foetal growth restriction" meddra_pt_id="10070531" />
    </Mention>
    <Mention id="M376" len="17" reason="from_drug_use" section="S2" start="6861" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Teratogenicity" meddra_llt_id="10043275" meddra_pt="Teratogenicity" meddra_pt_id="10043275" />
      <Normalization meddra_pt="Foetal damage" meddra_pt_id="10016852" />
      <Normalization meddra_pt="Maternal drugs affecting foetus" meddra_pt_id="10026923" />
    </Mention>
    <Mention id="M317" len="11" reason="AE_animal" section="S2" start="6915" type="NonOSE_AE">
      <Normalization meddra_llt="Teratogenicity" meddra_llt_id="10043275" meddra_pt="Teratogenicity" meddra_pt_id="10043275" />
      <Normalization meddra_pt="Foetal damage" meddra_pt_id="10016852" />
      <Normalization meddra_pt="Maternal drugs affecting foetus" meddra_pt_id="10026923" />
    </Mention>
    <Mention id="M318" len="18" reason="AE_animal" section="S2" start="6931" type="NonOSE_AE">
      <Normalization meddra_llt="Teratogenicity" meddra_llt_id="10043275" meddra_pt="Teratogenicity" meddra_pt_id="10043275" />
      <Normalization meddra_pt="Foetal damage" meddra_pt_id="10016852" />
      <Normalization meddra_pt="Maternal drugs affecting foetus" meddra_pt_id="10026923" />
    </Mention>
    <Mention id="M319" len="8" reason="AE_only_as_instruction" section="S2" start="7055" type="NonOSE_AE">
      <Normalization meddra_llt="Pregnant" meddra_llt_id="10036586" meddra_pt="Pregnancy" meddra_pt_id="10036556" />
    </Mention>
    <Mention id="M377" len="4,21,8" reason="from_drug_use" section="S2" start="7240,7256,7299" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Reproductive toxicity male" meddra_llt_id="10074274" meddra_pt="Reproductive toxicity" meddra_pt_id="10074268" />
      <Normalization meddra_pt="Reproductive tract disorder" meddra_pt_id="10061483" />
    </Mention>
    <Mention id="M379" len="4,9,8" reason="from_drug_use" section="S2" start="7240,7282,7299" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fertility male decreased" meddra_llt_id="10016470" meddra_pt="Infertility male" meddra_pt_id="10021929" />
    </Mention>
    <Mention id="M378" len="28,8" reason="from_drug_use" section="S2" start="7249,7299" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Reproductive toxicity female" meddra_llt_id="10074275" meddra_pt="Reproductive toxicity" meddra_pt_id="10074268" />
      <Normalization meddra_pt="Reproductive tract disorder" meddra_pt_id="10061483" />
    </Mention>
    <Mention id="M380" len="6,9,8" reason="from_drug_use" section="S2" start="7249,7282,7299" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fertility decreased female" meddra_llt_id="10016463" meddra_pt="Infertility female" meddra_pt_id="10021928" />
    </Mention>
    <Mention id="M381" len="25" reason="from_drug_use" section="S2" start="7374" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Reproductive toxicity female" meddra_llt_id="10074275" meddra_pt="Reproductive toxicity" meddra_pt_id="10074268" />
      <Normalization meddra_pt="Reproductive tract disorder" meddra_pt_id="10061483" />
    </Mention>
    <Mention id="M382" len="15,15" reason="from_drug_use" section="S2" start="7374,7404" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Spermatogenesis abnormal" meddra_llt_id="10041493" meddra_pt="Spermatogenesis abnormal" meddra_pt_id="10041493" />
    </Mention>
    <Mention id="M383" len="9" reason="from_drug_use" section="S2" start="7434" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Sterility" meddra_llt_id="10042012" meddra_pt="Infertility" meddra_pt_id="10021926" />
    </Mention>
    <Mention id="M320" len="9" reason="AE_only_as_instruction" section="S2" start="7474" type="NonOSE_AE">
      <Normalization meddra_llt="Sterility" meddra_llt_id="10042012" meddra_pt="Infertility" meddra_pt_id="10021926" />
    </Mention>
    <Mention id="M323" len="34" reason="AE_only_as_instruction" section="S2" start="7616" type="NonOSE_AE">
      <Normalization meddra_llt="Sterility" meddra_llt_id="10042012" meddra_pt="Infertility" meddra_pt_id="10021926" />
    </Mention>
    <Mention id="M321" len="11" reason="AE_only_as_instruction" section="S2" start="7732" type="NonOSE_AE">
      <Normalization meddra_llt="Infertility" meddra_llt_id="10021926" meddra_pt="Infertility" meddra_pt_id="10021926" />
    </Mention>
    <Mention id="M384" len="35" reason="from_drug_use" section="S2" start="7859" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Wound healing delayed" meddra_llt_id="10048036" meddra_pt="Impaired healing" meddra_pt_id="10021519" />
    </Mention>
    <Mention id="M385" len="12" reason="from_drug_use" section="S2" start="7922" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hyponatremia" meddra_llt_id="10021038" meddra_pt="Hyponatraemia" meddra_pt_id="10021036" />
    </Mention>
    <Mention id="M388" len="26" reason="from_drug_use" section="S2" start="7951" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hypervolemia" meddra_llt_id="10020920" meddra_pt="Hypervolaemia" meddra_pt_id="10020919" />
    </Mention>
    <Mention id="M387" len="24" reason="from_drug_use" section="S2" start="7979" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Water intoxication" meddra_llt_id="10047837" meddra_pt="Water intoxication" meddra_pt_id="10047837" />
    </Mention>
    <Mention id="M386" len="86" reason="from_drug_use" section="S2" start="8011" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Inappropriate antidiuretic hormone secretion" meddra_llt_id="10053198" meddra_pt="Inappropriate antidiuretic hormone secretion" meddra_pt_id="10053198" />
    </Mention>
    <Mention id="M322" len="5" reason="general_term" section="S2" start="8113" type="NonOSE_AE">
      <Normalization meddra_llt="Death" meddra_llt_id="10011906" meddra_pt="Death" meddra_pt_id="10011906" />
    </Mention>
  </Mentions>
</GoldLabel>